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Abstract 
 
 
Leukocyte recruitment from blood to tissues is a critical step of the immune system to 
protect against pathogens and provide tissue repair. While myeloid cell recruitment is 
a hallmark in inflammatory conditions, lymphocyte recirculation through tissues is an 
important feature of immune surveillance of an organism at steady state. Thus far, 
various molecules have been implicated in these migratory processes including 
chemokines and adhesion molecules. However, how this fundamental process of 
immunity is being regulated at the organismal level at different times is unknown. 
Here, we describe mechanisms that govern a non-continuous but oscillatory behavior 
in the infiltration of lymphoid and myeloid cells to different tissues in the mouse. Our 
data indicate the existence of a leukocyte- and tissue-specific oscillatory molecular 
signature in the expression of pro-migratory factors. Specifically, robust circadian 
oscillations, exhibiting a period length of ~24h, occur in cellular numbers in murine 
lymph nodes, showing a ~2-fold difference with a trough at the onset of the 
behavioral rest phase (light) and a peak at the onset of the active phase (dark). 
Oscillations were observed in the capacity of lymphocytes to home to lymph nodes, 
peaking at the onset of the activity phase, and to exit lymph nodes via efferent lymph, 
peaking during the rest phase. Using lineage-specific genetic ablation of circadian 
rhythmicity in T and B cells we demonstrate this to be dependent on both lymphocyte 
and endothelial oscillations in cell surface receptors. Taken together, our data show 
discrete tissue and leukocyte mechanisms that control rhythmic leukocyte trafficking 
and provide new insights into the temporal control of innate and adaptive immunity. 
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1.1  The lymphatic system 
 
1.1.1 The lymphatic vasculature 
 
In order to survey for antigens, leukocytes leave the bone marrow and thymus, from 
where they originate and circulate through blood, tissues, secondary lymphoid organs 
and lymph. Hippocrates and Aristoteles were the very first to mention the existence of 
lymphatic vessels, with Erasistratuts from Alexandria being the first one who 
mentioned ‘milky arteries’ in the mesentery (Wigle & Oliver 1999; Banerji et al. 1999). 
But it took more than 2000 years to reveal the detailed characteristics and specific 
markers of the lymphatic system with the help of modern microscopy techniques. 
The lymphatic vasculature is unique to vertebrates and is composed of tissue 
(afferent lymphatics) and lymph node (LN) (efferent lymphatics) draining lymphatic 
vessels. In contrast to blood vessels, tissue-draining lymphatic vessels are blind-
ended, unidirectional absorptive vessels that can be found almost everywhere, 
except in the bone marrow. Even the central nervous system, which has long been 
thought not to be connected to the lymphatic system, does contain lymphatic vessel-
like structures around the meninges (Louveau et al. 2015).  
The basic principle of the lymphatic vessel system is that afferent lymphatic vessels 
absorb immune cells, interstitial solutes and macromolecules that extravasate for 
example from blood. These lymphatic capillaries are connected to bigger collecting 
vessels, which contain valves that help drive the lymph actively forward in concert 
with smooth muscle cell contraction. Multiple afferent vessels lead to a tissue 
draining lymph node, whereas efferent lymph vessels can also be directly connected 
to the venous circulation (Figure 1.1).  
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Figure 1.1 The lymphatic system 
Lymphatic and pulmonary lymphatic capillaries absorb interstitial fluid and immune cells 
which extravasate from blood in peripheral tissues and transport these via afferent lymphatic 
vessels to a lymph node. Lymph fluid and accompanying cells exit the lymph node via an 
efferent lymphatic vessel, and finally drain back into blood, predominantly via the thoracic 
duct (Margaris & Black 2012). 
 
After percolating through the lymph node, lymph fluid exits the lymph node via one 
efferent lymphatic vessel and flows either to another lymph node or enters collecting 
vessels, the lymphatic ducts. Most organs drain into the thoracic duct, while only the 
right arm and chest drain into the right lymphatic duct (Figure 1.2).  
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Figure 1.2 Major Trunks and Ducts of the Lymphatic System 
Rough classification of body parts which drain either into the right lymphatic duct or the 
cisterna chyli of the thoracic duct (Fretham 2014). 
 
The majority of plasma, which extravasates from blood is transported back through 
this system, highlighting its important role for body fluid homeostasis. Interestingly, 
lymphatic endothelial cells (LECs) which cover the inner walls of lymphatic vessels 
do not only play a passive role by serving as highways for lymph-borne cells, but also 
actively regulate several immune processes. For instance in the case of immune 
tolerance, LECs function as antigen-presenting cells: In some cases, leukocytes can 
escape thymic negative selection. By expressing tissue antigens such as MHC I or 
PD-L1, LECs are able to inactivate self-reactive CD8 T-cells, thereby serving as 
systemic mediators of peripheral immune tolerance (Cohen et al. 2010). 
 
  
  Introduction 
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1.2  Homing of cells into lymph nodes 
 
1.2.1 Checkpoint for Lymph node homing: High endothelial 
venules 
 
Lymph nodes are key players in innate and adaptive immune responses. They are 
the sieve, where lymphocytes scan dendritic cells and fibroblastic reticular cells 
(FRCs) for activating, tolerogenic or homeostatic stimuli (Ager & May 2015). 
In 1964, Sir James Gowan injected radioactively labelled cells into rats and could 
demonstrate that leukocytes continuously traffic from blood to secondary lymphoid 
organs (SLOs) and back to blood. He described post-capillary venules in lymphoid 
organs as the main entry sites for cells (J. L. Gowans 1964, Girard et al. 2012;). But it 
took decades to decipher the characteristics and the exact role of these venules in 
the regulation of cellular entry into SLOs. In the lymph node, due to their 
morphological features, they became known as high endothelial venules (HEVs). 
HEVs are, as Sir James Gowan postulated, post-capillary venules, which lie 
downstream of incoming arteries of SLOs and can be found in the outer cortex or the 
B-cell area.  They consist of a branched network of vessels that form circuits in order 
to connect incoming arteries with the collecting vein that exits lymph nodes. These 
vessels are relatively large in the paracortex and the T-cell area of lymph nodes and 
decrease in size towards cortical-paracortical junctions. In the medulla, these vessels 
merge with venules, which drain into the collecting vein and subsequently exit lymph 
nodes (Figure 1.3).  
HEVs are characterized by a cuboidal morphology, referring to their tall (high) 
endothelium, a thick apical glycocalyx and a basal lamina that is coated with 
pericytes and follicular reticular cells (FRCs). The apical glycocalyx is made up of 
sialomucins, which are also known as peripheral node adressins (PNAd), and are 
specific for lymph nodes of peripheral tissues. In mucosal lymphoid organs another 
protein can be found on the apical side of HEVs, MAdCAM-1, which is a ligand for 
the leukocyte integrin α4β7. In contrast to PNAd, MAdCAM-1 is not specific for lymph 
nodes, as it is also being expressed on blood vessels in the spleen. 
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Figure 1.3 Organization of the vessel system in lymph nodes 
Lymph nodes have two different incoming vessel structures relevant for leukocytes, afferent 
lymphatic vessels and HEVs. Skin-draining cells (most prominently dendritic cells) enter 
lymph nodes via afferent lymphatic vessels, whereas blood-derived cells enter lymph nodes 
via HEVs (see text for details). Skin-draining and blood-derived cells leave lymph nodes via 
an efferent lymphatic vessel or as is the case for some dendritic cell populations that 
undergo apoptosis in the lymph node (Trevaskis et al. 2015). 
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1.2.2 The leukocyte adhesion cascade 
 
Although HEVs can also be found during chronic inflammation in non-lymphoid 
organs (Martinet et al. 2011), their general role is to serve as checkpoints and 
facilitate the entry of leukocytes from the bloodstream into lymph nodes.  
Homing of leukocytes into lymph nodes follows a complex multistep adhesion and 
migration cascade, including leukocyte tethering and rolling, followed by firm 
adhesion, crawling and transmigration (Figure 1.4). 
The leukocyte adhesion cascade is initiated by L-selectin (CD62L) on the side of the 
homing cell. CD62L recognizes the carbohydrate determinant sialic acid α2-3Galβ1-
4(Fucα1-3(sulpho-6)) GlcNAcβ1-R (6-sulpho sialyl Lewis X), which is expressed by 
HEVs and presented by PNAd. This apically expressed carbohydrate supports 
tethering and rolling of CD62Lhigh leukocytes and is crucial for homing, as blocking of 
this interaction with the anti-L-selectin antibody MECA-79 results in a functional block 
of leukocyte homing to the lymph node (Umemoto et al. 2006).  
In the next step, lymphocyte arrest is mediated via chemokine-induced activation of 
integrins. The most important chemokines for lymph node migration are CCL21 for T-
cells, which is produced by HEVs and FRCs and presented by heparane sulfate, and 
CXCL12 and CXCL13 for T- and B-cells respectively, which are produced by follicular 
dendritic cells (FDCs) and FRCs and then transcytosed to the luminal surface of 
HEVs (von Andrian & Mempel 2003). These chemokines are recognized by their 
respective chemokine receptors (CCR7 for CCL21, CXCR4 for CXCL12 and CXCR5 
for CXCL13) on the leukocyte and initiate binding of LFA-1 to ICAM-1 and ICAM-2, or 
MAdCAM-1 in mesenteric lymphoid organs. This interaction of ICAM-1 with LFA-1 
supports the arrest of cells on the inner luminal surface of HEV and enables 
leukocytes to crawl along HEV (Warnock et al. 1998).  
In the final step leukocytes cross the venule either via paracellular migration or 
transcellular transmigration (Nieminen et al. 2006). For the latter mode of migration, 
leukocytes accumulate in extracellular HEV pockets, before they enter the lymph 
node parenchyma. This process is regulated by HEV-derived lysophosphatidic acid 
(LPA), which increases cell motility for transmigration and might control together with 
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- 18 - 
 
sphingosine-1-phosphate (S1P) the accumulation of leukocytes in an HEV pocket 
(Bai et al. 2013; Mionnet et al. 2011). 
 
 
Figure 1.4 The leukocyte adhesion cascade 
Schematic illustration of the coordinated steps of leukocyte recruitment from HEVs into 
lymph nodes. CD62L and PNAd mediated rolling and tethering is followed by adhesion and 
crawling of leukocytes, which involves chemokines, chemokine receptors and adhesion 
molecules. After finding an exit point, leukocytes transmigrate and accumulate in HEV 
pockets, before finally extravasating into the lymph node parenchyma (Girard et al. 2012). 
Depending on the cell type, leukocytes move to different areas within the LN. After 
crossing HEVs, T-cells are retained in perivascular channels that are surrounded by 
FRCs. This temporal lingering has been hypothesized to most likely increase the 
chance for T-cell DC encounters (Mempel et al. 2004). Afterwards, T-cells crawl 
along stromal networks to T- and B-cell areas of the lymph node (Bajénoff et al. 
2006). These stromal networks are made up of FRCs, which produce the 
chemokines CCL21 and CCL19 and are responsible for the random migration pattern 
of T-cells (Miller et al. 2002).  
In contrast to T-cells, B-cells remain significantly longer close to their HEV entry site, 
as they survey locally for DCs at these points (Qi 2006). After three to four hours, 
they start crawling towards the T-cell area or the B-cell follicle (Bajénoff et al. 2006). 
This process is mediated by the chemokine CXCL13, which is produced by FDCs 
and binds to CXCR5 on the B-cell (Ansel et al. 2000). 
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1.3  Leukocyte egress from lymphoid organs  
 
1.3.1 Egress of cells into efferent lymphatic vessels  
 
After immune cells have homed to SLOs and have scanned for antigen, leukocytes 
leave the lymph node to continue their quest for antigen survey in other areas – in 
case they have not encountered it (Cahalan & Parker 2008). 
For this process, sphingosine-1-phosphate (S1P) plays a crucial role. S1P is a 
chemoattractant lipid, whose biosynthesis starts with serine and palmitoyl coenzyme 
A in the endoplasmic reticulum. After reduction and dehydrogenation, ceramide is 
formed, which is metabolised in the Golgi-apparatus to sphingosine. Sphingosine can 
then either be phosphorylated by sphingosine kinase 1 (SphK1) or Sphk2 to S1P 
(Maceyka & Spiegel 2014).  
Fundamental studies have shown that S1P is involved in many physiological 
processes, including vascular integrity (Herzog et al. 2013), hematopoietic stem cell 
trafficking (Golan et al. 2012; Juarez et al. 2012), ubiquitin functions (Alvarez et al. 
2010), histone deacetylation (Harikumar et al. 2009) and immune cell trafficking 
(Pappu et al. 2007) (Figure 1.5). 
The main sources for blood S1P are erythrocytes and vascular endothelial cells 
(Pappu et al. 2007; Venkataraman et al. 2008), whereas lymph S1P is produced by 
lymphatic endothelial cells (Pham et al. 2010). For a proper function of immune cell 
trafficking, the maintenance of a S1P gradient is crucial, with a high S1P 
concentration in blood (~1µM) and lymph (~100 nM) and low levels in tissues (~nM) 
(Cyster & Schwab 2012). This gradient is ensured by a relative short plasma half-life 
of S1P (~15min) and a fast enzymatic degradation of S1P in tissues. Therefore 
plasma S1P does not reach lymph nodes or lymph. This maintenance can be 
disturbed, when mice are administered food colorant 2-acetyl-4-
tetrahydroxybutylimidazole (THI). THI inhibits the S1P degrading enzyme 
Sphingosine-1-phosphate lyase (SPL), leading to a more than 100-fold increase of 
lymphoid tissue S1P. This results in lymphopenia as leukocytes do not leave lymph 
nodes anymore and a defect in immune cell trafficking (Schwab et al. 2005).  
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Figure 1.5 S1P and S1P1 control leukocyte trafficking 
S1P is bound to apolipoprotein M in high-density lipoprotein and albumin, forming a gradient 
between blood and lymphoid tissues. High S1P levels in blood lead to downregulation of 
S1P1. After cells have homed to lymphoid tissues, low S1P levels cause S1P1 upregulation, 
thus promoting S1P1-dependent leukocyte egress (Maceyka & Spiegel 2014). 
 
S1P mediates its cell-type dependent functions via five specific cell surface receptors 
(S1P1-5), all G-protein-coupled receptors that trigger downstream signalling 
pathways and numerous physiological processes. Although the general consensus is 
that S1P signalling is mediated in a paracrine and/or autocrine fashion, it might be 
feasible that S1P does not need to be secreted for proper function, as the molecule 
enters the binding pocket of the receptor by sliding in the plane of the membrane 
(Hanson et al. 2012). This might suggest, that S1P does not need to be secreted at 
all for proper function.  
S1P was first shown in 1998 to activate the heterotrimeric guanine nucleotide binding 
protein (G-protein)-coupled orphan receptor EDG-1, also known as S1P1 (Lee et al. 
1998). S1P1 is being expressed throughout the body and thus many physiological 
functions of the receptor have been identified, being critical in embryonic 
development, as S1pr1-/- embryos die from haemorrhage due to incomplete vascular  
maturation (Liu et al. 2000), and in maintaining the vascular integrity of HEVs 
(Herzog et al. 2013). The binding of S1P to S1P1 leads to Rac activation, trans-
endothelial migration of T-cells and LN egress (Faroudi et al. 2010).  
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This pathway functions for S1P concentrations from 0.1-1nM, as they occur in lymph 
nodes. For locations with higher concentrations of S1P, the receptor is being 
downregulated as it is the case for blood or lymph (Schwab et al. 2005). Experiments 
with Sphk1-/- mice emphasized the importance of the S1P gradient. Knocking out 
Sphk1 in lymphatic endothelial cells, leads to a loss of S1P in lymph. Although S1P 
levels in plasma remain normal, the S1P gradient is impaired and leukocytes are not 
able to leave the lymph node any longer (Pham et al. 2010). 
 
1.3.2 Control of leukocyte egress 
 
Besides the importance in vascular functions, S1P1 plays a crucial role in leukocyte 
trafficking, where it is responsible for the egress of T- and B-cells from thymus and 
lymph nodes. The major S1P1 function in the lymph node is to overcome the 
retention signal mediated by the chemokine receptor CCR7 as shown by Pham and 
colleagues (Figure 1.6).  
 
 
 
Figure 1.6 Factors promoting leukocyte retention versus egress 
The fine-tuned counter play between S1P1 and CCR7 decides the fate of lymphocytes. 
When the CCR7 signal overrides S1P1, retention of the leukocyte is favored. In the other 
case, leukocyte egress is promoted (Cyster & Schwab 2012).   
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When S1pr1-/- T and B-cells were adoptively transferred, they homed into the lymph 
node, but did not egress the lymph node. After incubation with PTX, a reagent that 
inactives Gai-mediated signalling as promoted by chemokine receptors, these cells 
were able to exit the lymph node again (Pham et al. 2008). 
In some cases, S1P1 is being downregulated to ensure proper immune function. For 
example under inflammatory conditions, it is necessary that lymphocyte retention 
takes place in LNs in order for T-cells to have more time to scan DCs and encounter 
cognate antigen (Cyster & Schwab 2012).   
This process is mediated by CD69, a cell surface glycoprotein, which associates and 
forms a complex with S1P1 and in this manner downregulates S1P1 expression 
levels. Thus, T- and B-cells do not leave the inflamed lymph node anymore and have 
more time for scanning the lymph node and producing a productive immune 
response (Shiow et al. 2006). Another mechanism, by which surface expression of 
S1P1 can be modulated, is via transcriptional modulation by Krüppel-like Factor 2 
(KLF2). In T-cells but not B-cells, KLF2 binds to and activates the promoter region of 
S1P1 (Carlson et al. 2006; Bai et al. 2007). As a consequence, T-cells can egress 
from the thymus and SLOs. 
 
1.3.3 Pharmacological blockade of leukocyte egress  
 
For many decades, researchers strived for a method to modulate leukocyte egress 
from LNs using pharmacological reagents to prevent pathogenic T-cells from leaving 
the lymph node and thus stopping the cells from causing damage to other organs.  
This was finally achieved with the discovery of fingolimod, a drug that plays a major 
role in the treatment of multiple sclerosis. Multiple sclerosis is a chronic autoimmune 
disease and the leading cause of neurological disability in young and middle-aged 
adults. It is characterized by lesions, due to astrogliosis and a loss of 
oligodendrocytes, and demyelination. Fingolimod (FTY720/Gilenya; Novartis), was 
first described in 1995 and approved by the FDA (U.S. food and drug administration) 
in 2010 as the first orally available drug against multiple sclerosis (Brinkmann et al. 
2010).  
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FTY720 is a drug that interferes with the S1P1 levels on the surface of leukocytes 
(Figure 1.7). When FTY720 is given orally, it is being phosphorylated by SphK2 into 
its active form. FTY720-P can bind to all S1P receptors, except S1P2, which leads to 
S1P receptor down regulation. FTY720 therefore acts as a functional antagonist of 
S1P1 (Mandala et al. 2002). Pharmacologically, FTY720 can inhibit MS on two 
frontiers. By retaining pathogenic T-cells in lymph nodes, which as a consequence do 
not cross the blood brain barrier any more (Brinkmann et al. 2010) and by 
downmodulation of S1P1 on astrocytes, leading to reduced astrogliosis and recovery 
of nerve conduction (Choi et al. 2011). 
 
 
 
Figure 1.7 Mode of Action of FTY720 
After FTY720 is taken up orally, S1P receptors are being down-modulated in lymph nodes 
and the brain. Thus, pathogenic lymphocytes do not infiltrate into the central nervous system 
but stay in the lymph node. In the brain, down-modulation of S1P1 reduces demyelination, 
axonal loss and astrogliosis (Brinkmann et al. 2010). 
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1.4  Circadian rhythms 
 
1.4.1 Biological rhythms 
 
Most animals have developed biological clocks in order to adapt optimally to the 
environment they are being exposed to. These clocks are defined by their frequency 
(period length tau), which can range from seconds to years. Among mammals, 
ultradian, circadian and infradian biological rhythms play a major role.  
Ultradian (inner-day) rhythms have a relatively short period length of milliseconds to 
several hours and can be found in various patterns. Heart beat (average tau=1s), the 
nasal cycle, e.g. the partial congestion and decongestion of the nasal cavities (with a 
period length of 30 minutes till 14 hours, average tau=2.4h) are just two examples. In 
contrast to ultradian rhythms, infradian rhythms are described by long period lengths, 
ranging from several days, e.g. the human menstrual cycle (average tau=29.1), to 
years, such as the emerge cycles of cicada insects (average tau=17 years) (Gachon 
et al. 2004).  
Circadian rhythms exhibit a period length of approximately 24 hours and play a 
crucial role in the regulation of immune cell trafficking (Druzd et al. 2014).  
Bona fide circadian rhythms can be entrained, i.e. they adjust to different geophysical 
environments and persist over a range of physiological temperatures. They are also 
independent from external factors, such as light or food, which are the most important 
Zeitgebers or synchronizers of circadian rhythmicity (Green et al. 2008). Thus, a 
circadian rhythm can be entrained to different Zeitgebers (e.g. lighting regimes after 
jetlag), yet these Zeitgebers are not required for the oscillation per se, they are only 
required for the synchronization of the organism to the environment. Oscillations 
would also occur in constant conditions such as constant darkness. These circadian 
criteria are fulfilled for instance by core body temperature oscillations as well as 
plasma cortisol or plasma melatonin levels, which are therefore classical markers of 
circadian rhythms in mammals (Brown et al. 2002). Thus, non-circadian rhythms, 
observed for example only under a rhythmic 12h light/dark cycle but not under 
constant conditions are referred to as diurnal rhythms.  
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For mammals, two clock systems are responsible for the regulation of circadian 
rhythms, the central clock and the peripheral clocks. 
 
1.4.2 The molecular clock machinery 
 
Gene expression analyses revealed that a surprising amount of genes oscillate over 
the course of a day with approximately 10% of genes showing circadian expression 
patterns in liver and heart (Panda et al. 2002; Storch et al. 2002). 
Since circadian rhythms can be also observed for unicellular organisms as 
prokaryotes (Kondo et al. 1993), circadian oscillators must rely on intracellular 
mechanisms. Further analysis led to the identification of the core complex of the 
molecular clock, which consists of multiple transcription factors that interact together 
and form autoregulatory transcription-translation feedback loops (Figure 1.8).  
 
 
Figure 1.8 The circadian clock 
BMAL1 and CLOCK form a heterodimer complex which binds to E-box motifs in clock 
controlled genes and drives the auto regulatory feedback loop by activating the transcription 
of negative regulators, as Per and Cry. Further molecules, as for example NADH or 
peroxiredoxins (PRX) interfere in the molecular machinery dependent on their oxidation 
status (Scheiermann et al. 2013). 
 
 
 
  Introduction 
- 26 - 
 
The key transcription factors that operate the positive branch of the feedback loop 
are BMAL1 (brain and muscle aryl hydrocarbon receptor nuclear translocator 
(ARNT)-like 1, also known as ARNTL or MOP3) and CLOCK (circadian locomotor 
output cycles kaput) (Dunlap 1999). CLOCK-BMAL1 form a heterodimer complex, 
which binds to DNA E-Box response elements containing the nucleotide sequence 
CACGTG. They are thus able to induce the transcription of other clock genes or clock 
controlled genes (Darlington et al. 1998; Ueda et al. 2005; Hogenesch et al. 1998). 
These genes are fundamental components of the molecular clock machinery, as 
knocking out BMAL1 in mice is the only single gene deficiency that results in 
complete loss of circadian rhythmicity in constant darkness (Bunger et al. 2000). 
CLOCK-BMAL1 is regulating its own expression by promoting the negative branch of 
the feedback loop via two different paths. One is to induce the expression of three 
PERIOD proteins (PER, period circadian protein 1-3), and two CRY flavoproteins 
(cryptochrome 1 and 2). These proteins form PER-CRY heterodimer complexes, 
translocate to the nucleus and interact directly with the CLOCK-BMAL1 complex, 
leading to an inhibition of CLOCK and BMAL1 transcription (Jin et al. 1999; Griffin et 
al. 1999; Gekakis et al. 1998). 
 
The second one is to activate another transcriptional cycle, which is made up of REV-
ERBα and REV-ERBβ (encoded by Nr1d1 and Nr1d2) proteins. The REV-
ERBα/REV-ERBβ heterodimer complex inhibits BMAL1 transcription via Rev-
Erb/ROR response elements (Preitner et al. 2002).  
Transcription, translation and degradation of clock genes are under tight epigenetic 
control. Epigenetic histone modifications, like histone acetylation or methylation, are 
able to regulate both the development of whole T-cell subset and the expression of 
specific genes (Ramming et al. 2012). Crosio et al. showed that light itself is able to 
induce histone acetylation in neurons of the SCN. As a result, this leads to dynamic 
chromatin remodeling and higher transcription rates in circadian genes (Crosio et al. 
2000). 
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1.4.3 Central and peripheral clocks 
 
In order to orchestrate the billions of cells that are present in the body, an organism 
needs to orchestrate its cellular clocks. Lesion experiments in the brain led to the 
identification of an area, called the suprachiasmatic nucleus (SCN), which is essential 
for rhythmic activity and functions as the central clock of the body in mammals (Ralph 
et al. 1990; Silver et al. 1996) (Figure 1.9). 
This master pacemaker, situated directly above the optic chiasm in the anterior 
hypothalamus, consists of around 20.000 neurons. The key role of the SCN is to 
establish phase coherence with the environment and peripheral clocks of the body 
via direct and indirect signals. The SCN is the only clock system that is directly 
influenced by light input, which it receives via the retinohypothalamic tract. Light 
therefore functions as the main Zeitgeber (i.e. time giver) of the body (Golombek & 
Rosenstein 2010).  
 
 
Figure 1.9 Entrainment and synchronization of peripheral clocks by the central clock 
Light signals are being perceived via the eye and processed via the retinohypothalamic truct 
into the SCN. From here, the SCN orchestrates the circadian release of glucocorticoids from 
the adrenal gland or hematopoietic stem cells from the bone marrow via the release of 
adrenocorticotropic hormone (ACTH) over the humoral axis or the sympathetic nervous 
system (Scheiermann et al. 2013). 
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Moreover, feeding-fasting cycles and body temperature are important indirect 
Zeitgebers (Brown et al. 2002). For example, the SCN is able to entrain peripheral 
clocks in the liver by regulating the rest-activity cycle leading to different timing of 
feeding behavior (Damiola et al. 2000; Stokkan et al. 2001). As shown by Saini and 
colleagues, body temperature cycles can synchronize gene expression, a process 
that is heat shock factor 1-dependent (Saini et al. 2012). These data provide strong 
evidence for a link between metabolism and the circadian clock.  
Another key pathway of the SCN to entrain peripheral clocks and thus organs and 
cells that are not under direct environmental control in an opaque organism is via 
humoral and neuronal means. These pathways are mediated by the hypothalamus-
pituitary-adrenal (HPA) axis: The PVN (paraventricular and arcuate nuclei, located in 
the hypothalamus), which are controlled by excitatory and inhibitory SCN efferents, 
are able to induce the release of ACTH from the pituitary (Arjona & Sarkar 2008). 
This induces the production of glucocorticoids in the adrenal gland in a circadian 
manner, which can then bind to GR receptors. This process is also under direct 
circadian clock gene control as CLOCK regulates the transcriptional activity of the 
glucocorticoid receptor by acetylating its hinge region lysine cluster (Dickmeis 2009; 
Nader et al. 2009). In addition, glucocorticoids play an essential role in inflammatory 
processes, as they are known to up-regulate the expression of anti-inflammatory 
proteins and inhibit the synthesis of pro-inflammatory proteins (Elenkov et al. 2000). 
The glucocorticoid synthesis is also known to be regulated by intestinal epithelial 
cells (IECs), as IECs show a temporal circadian expression of clock genes (Asfeldt 
1971). Mukherji et al (Cell 2013) found that microbiota can modulate the circadian 
clock in IEC. During the behavioral active phase RORα activity is dominant, resulting 
in expression of toll-like receptors (TLRs) and low cortisone production. Furthermore, 
the intestine microbiota can interact with TLR, leading to low expression of REV-
ERBα. In the resting phase, REV-ERBα activity is dominant, resulting in high 
corticosterone production (Mukherji et al. 2013). This indicates the importance of 
entrainable oscillators like food and microbiota for circadian rhythmicity of non-brain 
tissues. As microbiota signaling deficiencies induce a prediabetic syndrome this is 
also important in the context of disease pathophysiology (Mukherji et al. 2013).  
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As mentioned before, oscillations in clock genes can be found in various tissues, 
such as the liver, adipose tissue and muscle (Yang et al. 2006). Interestingly, these 
peripheral clocks are not solely under control of the central clock. This was 
demonstrated by specifically disrupting circadian clock mechanism in hepatocytes. 
Although the majority of hepatic genes become arrhythmic, core clock components of 
the molecular clock as Per2 remain to oscillate in the absence of the molecular 
feedback loop (Kornmann et al. 2007). This suggests that these peripheral clocks do 
not only rely on input from the central clock, but also on metabolic Zeitgeber signals 
(Thaiss et al. 2016). These represent peripheral pacemaker cues, which are able to 
regulate the molecular clock and serve as metabolic regulators of circadian clock 
components (Albrecht 2012).  
Recent findings have provided evidence that peripheral clocks can also be found at 
the single cell level. With respect to the immune system, major clock genes and clock 
controlled transcription factors have been found to be expressed in natural killer cells, 
macrophages, dendritic cells, B cells and inflammatory monocytes (Silver, Arjona, 
Hughes, et al. 2012; Nguyen et al. 2013; Arjona & Sarkar 2005). In these cell the 
genes also show a rhythmic expression profile. In the case of macrophages, it could 
be even shown that roughly 8% of the macrophage transcriptome are under circadian 
control, including important regulators for pathogen recognition and cytokine 
secretion, such as ERK1, MEK1 and NFκB expression (Keller et al. 2009). However, 
data for T lymphocytes has thus been sparse. So far, it has been only shown, that 
Bmal1 and Nr1d1 are expressed and oscillate in CD4 T cells, whereas the 
physiological relevance is currently unknown (Hemmers & Rudensky 2015). 
In summary, a complex system of regulatory feedback loops exist which enables an 
organism to orchestrate its cellular clocks which can be found throughout the whole 
body.  
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1.4.4 Circadian rhythms in immune cell trafficking 
 
Over the past decades, research has provided striking evidence that integral parts of 
the immune system are under circadian control. Among these are cytokines, 
chemokines, chemokine receptors and adhesion molecules (Druzd et al. 2014). All 
these factors fluctuate in accordance with the rest-activity phase of the species, 
which depends on whether the species is diurnal (such as humans) or nocturnal 
(such as rodents) (Scheiermann et al. 2013).  
Regarding the circadian trafficking behavior of immune cells, the vast majority of 
research in this field has thus far focused on trafficking within blood, the bone marrow 
or tissues such as the cremaster muscle. It has been shown for hematopoietic stem 
and progenitor cells (HSPCs) that they oscillate in blood showing a peak during the 
behavioral rest phase (ZT5) and a trough at the beginning of the active phase (ZT13) 
(Méndez-Ferrer et al. 2008). For HSPCs, this is due to strong circadian modulation of 
the bone marrow microenvironment resulting in phases with higher egress of cells 
from the bone marrow and phases of stronger homing to the bone marrow. 
Specifically, enhanced homing to bone marrow is observed at ZT13, as the 
expression of P- and E-Selectins, VCAM-1 and CXCL12 peak towards the beginning 
of the active phase (Scheiermann et al. 2012). In contrast, the circadian homing 
behavior of leukocytes into other tissues is regulated more downstream of the 
leukocyte adhesion cascade, as ICAM-1 and CCL2 are the factors that regulate 
rhythmic leukocyte homing into mouse cremaster muscle tissue.  
T-cells in blood fluctuate in a similar circadian manner, whereas the nature of T-cell 
affects the phase of oscillation. Central memory and naïve CD4+ and CD8+ T-cells 
peak at night in human blood, due to a cortisol-induced upregulation of CXCR4. This 
allows circulating naïve and central memory T-cells to redistribute to bone marrow. In 
contrast, effector CD8+ T-cells counts peak during the day, being positively 
correlated with epinephrine rhythms (Dimitrov et al. 2009). 
Integral parts of adaptive immune response cells are also under tight control of clock 
genes: Bmal1-deficient mice show reduced levels of mature B-cells, as BMAL1 
seems to exclusively regulate the development of pre-B cells to mature B-cells (Sun 
et al. 2006). In contrast, the development of Th17 cells is under control of REV-
ERBα.  
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In this context, REV-ERBα can downregulate expression of the transcription factor 
NFIL3, which is itself a negative regulator of Th17 differentiation (Yu et al. 2013).  
Natural killer (NK) cells are critical components of innate immunity against fungal, 
bacterial and viral infections. In addition to the existence of functional molecular clock 
mechanisms in NK cells, the release of granzyme B and Perforin, which are essential 
for granule mediated cytolytic activity of NK cells, are also under circadian control 
(Arjona & Sarkar 2005). 
Taken together, the majority of myeloid and lymphoid cells exhibit a circadian 
oscillation with respect to numbers in blood. Regarding the relevance of these 
oscillations in some cell types, a benefit in the immune response is suggested, as 
described below.  
 
1.4.5 Circadian rhythms in the immune response 
 
The immune system itself represents a pivotal role in host defense, as its main task is 
to protect the organism against pathogens, such as parasites, bacteria or viruses. 
This difficult task is mediated via two defense systems, the innate and adaptive 
immune response.  
In general, innate immunity leads to a nonspecific but rapid immune response, in 
which NK cells, mononuclear phagocytes (monocytes and macrophages) and 
granulocytes (neutrophils, eosinophils, basophils and mast cells) kill pathogens via 
phagocytosis or secreting antimicrobial substances. Furthermore, the innate immune 
system is able to activate the adaptive immune system, which leads to a slower but 
antigen-specific immune response. This process is mediated by T and B 
lymphocytes, and antigen-presenting cells such as dendritic cells.  
As described above, most cell types, which take part in the immune response 
possess functional clock genes. Meanwhile, it is also known that these clock genes 
regulate the rhythmic expression of molecules, which are involved in immune 
responses.  
Macrophages for example, display time-of-day-dependent secretion of TNFα and IL-6 
production after treatment with lipopolysaccharide (LPS), a membrane compound of 
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gram-negative bacteria (Keller et al. 2009). When challenging macrophages with a 
TLR9-dependent model of sepsis, disease severity also depended on the timing of 
sepsis induction. The latter effect was mediated via rhythmic expression of TLR9, 
indicating an important link between the circadian system and innate immune 
response (Silver et al. 2012).  
Another type of myeloid cells, monocytes, exhibit time-of-day dependent differences 
in the immune response following pathogen challenge. A study by Nguyen and 
colleagues reported that Bmal1 regulates diurnal oscillations of Ly6Chi inflammatory 
monocytes, which control their trafficking to sites of inflammation (Nguyen et al. 
2013). When challenging mice with a lethal dose of Listeria monocytogenes, a gram-
positive bacterium, towards the end of the active phase they observed higher survival 
rates compared to a challenge in the middle of the rest phase. Interestingly, mice, 
which lack Bmal1 in myeloid cells, showed higher lethality than wild-type animals due 
to a higher pro-inflammatory state in these mice. Mechanistically, they unveiled that 
Bmal1 in myeloid cells is able to suppress inflammation by regulating Ccl2 and Ccl8 
expression, two important chemokines in acute and chronic inflammation (Druzd & 
Scheiermann 2013; Nguyen et al. 2013).  
In the case of adaptive immunity, Fernandes and colleagues were the first ones to 
demonstrate, that the adaptive immune response is under circadian control 
(Fernandes et al. 1976; Labrecque & Cermakian 2015). Their findings showed higher 
antibody titers at specific times in mice after immunization with sheep red blood cells, 
were recently also confirmed in the human system, as Long et al. demonstrated that 
the antibody responses against certain flu strains is higher in the morning compared 
to afternoon immunization (Long et al. 2016). Whether this is due to higher T-cell 
proliferation, as has been shown for anti-CD3 stimulation and Th17 differentiation 
(Fortier et al. 2011; Yu et al. 2013), or due to other factors, such as higher rates of 
antigen presentation is currently not known. 
In summary, it has been shown that integral parts of both innate and adaptive 
immune responses are under circadian control. However, little is known about the 
interplay between circadian rhythmicity and T-cell mediated immune responses in 
lymphoid organs. 
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2.1  Animal husbandry 
 
7-8 weeks old C57BL/6 wild type (WT) mice were obtained from Charles River 
Laboratories (Sulzfeld, Germany). Bmal1flox/flox, S1pr1 flox/flox, Cd4cre, Cd4creert2, 
Cd19cre, mice were purchased from Jackson Laboratories and crossbred on-site to 
obtain Bmal1flox/flox x Cd4cre, Bmalflox/flox x Cd19cre, S1pr1 flox/+ x Cd4cre, S1pr1 flox/+ x 
Cd19cre, S1p1 flox/+ x Cd4creert2 animals. All mice were maintained under a 12h light 
- 12h dark lighting schedule with food and water available ad libitum. In some 
experiments, mice were put in light cyclers to change light regime or were kept in 
constant darkness. For knockout experiments, age and gender matched littermates 
were used as a control. All mice were maintained and bred at the Walter-Brendel 
Center for Experimental Medicine, Ludwig Maximilians Universität, Munich, Germany. 
All work within this project was carried out in accordance with the German Law of 
Animal Welfare and approved by the Regierung of Oberbayern. 
 
2.2  Genotyping by PCR 
 
To determine the genotype of transgenic lines (Bmal1flox/flox x Cd4cre, Bmal1flox/flox x 
Cd19cre, S1pr1flox/+ x Cd4cre, S1pr1flox/+ x Cd19cre, S1pr1flox/+ x Cd4creert2), mice 
were genotyped by polymerase chain reaction (PCR). For this purpose, ear samples 
or tail tips were harvested and digested overnight at 55°C in 200µl lysis buffer (5mM 
EDTA, 200mM NaCl, 0.2% SDS in 100mM Tris-HCl, pH 8.5) containing proteinase K 
(1:200 units). On the next day, samples were gently mixed and centrifuged at 
12,700g for 15 minutes. The supernatant was transferred to tubes containing 200µl 
isopropanol, mixed thoroughly and centrifuged at 12,700g for 10 minutes. Afterwards 
supernatant was removed and the pellet was dissolved in 100µl TE buffer and stored 
at -20°C. Samples were then incubated for 1 hour at 37°C before being used in the 
PCR reaction mix (Table 2.1) 
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Table 2.1 PCR reaction mix used for genotyping 
Item Volume (µl) 
DNA 1 
Dreamtaq 10 
Forward primer 0.1 
Reverse primer 0.2 
Water 8.6 
 
Samples were initially denatured at 94°C for 3 minutes, followed by 35 amplification 
cycles of DNA denaturation (94°C, 30 sec), primer annealing (55°C for Bmal1, 56°C 
for S1pr1, 30 sec), DNA polymerization (72°C, 30 sec) and a final primer extension 
(72°C, 2 minutes). Assessment of the Cre status was performed by a denaturation at 
95°C for 3 minutes, followed by 38 cycles of DNA denaturation (95°C, 20 sec), primer 
annealing (62°C, 30 sec), DNA polymerization (72°C, 30 sec) and a final primer 
extension (72°C, 10 minutes).  
Primer sequences were used as shown in Table 2.2. All PCR products were run on a 
1% agarose-TAE gel containing gel red to visualize DNA bands and evaluated under 
ultraviolet light on a Gel iX20 Imager (Intas Science Imaging Instruments GmbH, 
Göttingen, Germany) (Figure 2.1) . 
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Figure 2.1 PCR genotyping gel 
Exemplary genotyping of Bmal1flox/flox and Bmal1flox/+ mice and their respective Cd4cre 
status. Mutant (431 bp), heterozygous (327bp and 431bp) and Cre+ (324bp) bands were 
detected. 
 
 
 
Table 2.2 PCR primers used for genotyping 
PCR Primers Sequence 
S1pr1 flox forward GAG CGG AGG AAG TTA AAA GTG 
S1pr1 flox reverse CCT CCT AAG AGA TTG CAG CAA 
Bmal1 flox forward ACT GGA AGT AAC TTT ATC AAA CTG 
Bmal1 flox reverse CTG ACC AAC TTG CTA ACA ATT A 
Generic Cre forward GCG GTC TGG CAG TAA AAA CTA TC 
Generic Cre reverse GTG AAA CAG CAT TGC TGT CAC TT 
 
 
mutant heterozygous 
 
cre+ 
  Material and Methods 
- 37 - 
 
2.3  Surgical techniques 
 
2.3.1 Lymph cannulation 
 
In order to obtain lymph from animals, lymph cannulation of the thoracic duct was 
performed on the basis of a protocol described by Ionac in 2013 (Ionac 2003). 
However, as the method established by Ionac often led to contamination of lymph 
with blood, the surgical approach had to be modified. 40 minutes prior to cannulation, 
200µl olive oil was administered intragastrally. 10 minutes prior to cannulation, mice 
were anaesthetized intraperitoneally with 100 mg/kg ketamine, 20 mg/kg xylazine 
and 1% acepromazin. An incision was performed along the costal arch and the 
abdomen was opened as depicted (Figure 2.2).  
 
 
Figure 2.2 Cannulation of mesenteric lymphatic vessels 
(Left side) Lymphatic structures in a rat showing mesenteric lymph vessels and the thoracic 
duct. (Right side) Technique, which was established in the lab to cannulate mesenteric 
lymph vessels in the mouse. 
 
 
The dorsum was perforated, slightly above the adrenal gland, using a 19G 1.1 x 
40mm needle in order to implement the suction tube. The suction tube consisted on 
the one end of a syringe equipped with a 19G needle and a 130mm polyethylene 
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tube (LOT: 201600 REF:800/100/100 Smiths Medical). On the other end, the tip of a 
30G 0.3 x 13mm needle was broken off and placed in the polyethylene tube. Before 
placing the suction tube into the 19G needle, the system was flushed with 20 µl 
EDTA 0.5M to avoid clotting of the lymph. After placing the suction tube into the 19G 
needle, the needle was removed and mesenteric lymph vessels were cannulated by 
gently perforating the vessel in a flat angel. Lymph fluid was drawn for 40 minutes. 
On average 72.15µl was obtained, which equals a lymph flow rate of ~1.8 µl/min. 
Lymph leukocyte counts were measured using a ProCyte DX cell counter (IDEXX, 
Ludwigsburg, Germany) and analyzed by flow cytometry as described below. 
 
2.4  Pharmacological inhibition of lymph node egress 
 
In order to study egress dynamics of lymphocytes from lymph nodes, chemical 
compounds were administered prior to lymph cannulation to inhibit lymph node 
egress. For FTY720 treatment, 1mg/kg FTY720 was given intraperitoneally one hour 
prior to cannulation. In some experiments, subsequent dilutions were used. For 
control mice, 200µl of 0.9% NaCl was injected. For SEW2871 treatment, 10mg/kg 
SEW2871 was injected two hours prior to cannulation and 25µl dimethylformamide 
was administered as a control.  
 
2.5 Adoptive transfer studies and homing block 
 
To investigate the dwell time of leukocytes in lymph nodes and the respective roles of 
leukocyte versus endothelial factors in lymph node homing, cell transfer experiments 
were performed. To achieve this, spleen and peripheral lymph nodes (pLN) were 
harvested from donor mice and processed through a cell strainer (40µm, Thermo 
Fisher Scientific, Waltham, USA). After red blood cell lysis (described below) for 
spleen, leukocytes from spleen and lymph nodes were counted with a Neubauer 
counting chamber and mixed with a ratio of 80:20 (spleen:pLN).  
Subsequently, leukocytes were labeled with 1.5µM of carboxyfluorescein 
succinimidyl ester (CFSE, Thermo Fisher Scientific, Waltham, USA) or 2.5µM 
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CMTPX (Thermo Fisher Scientific, Waltham, USA) in PBS containing 0.2% BSA and 
2mM EDTA for 20min at 37°C and washed 4 times. Finally, 10-20 x106 cells were 
injected intravenously into recipient mice. Two hours later, inguinal lymph nodes of 
recipient mice were harvested and the amount of homed cells was analyzed by flow 
cytometry as described below. In some experiments, lymph node homing was 
inhibited to perform analyses of leukocyte transit by using blocking antibodies against 
CD11a (αL-integrin) and CD49d (α4-integrin). To achieve this, lymph node entry was 
blocked two and 12 hours after adoptive cell transfer by administration of 100µg anti-
αL (CD11a, clone M17/4; BioXCell) and 100µg anti-α4 (CD49d, clone PS/2; 
BioXCell) antibodies in PBS intraperitoneally. To investigate the role of chemokine 
receptors in leukocyte homing, cells were labeled with CFSE or CMTPX and pre-
incubated with a 200ng/ml pertussis toxin (PTX) pulse for 10 min at 37°C as 
described before (Lo et al. 2005). After 4 times washing, cells were co-injected with 
untreated cells into recipient mice and the amount of homed cells was analyzed as 
described before.  
Between all adoptive transfer experiments, dyes were switched to avoid potential 
dye-specific effects. 
 
2.6 Blood sample collection 
 
Blood was taken by punctuation of the retrobulbar venous plexus of anaesthetized 
mice into EDTA-coated capillary tubes (Microvete 300). Blood leukocyte counts were 
measured using a ProCyte DX cell counter (IDEXX, Ludwigsburg, Germany) and 
analyzed by flow cytometry as described below.  
 
2.7 Flow Cytometry 
 
To decipher the distribution of leukocyte subsets, harvested organs, blood and lymph 
were analyzed via flow cytometry. Blood and Lymph was drawn as described above, 
lymph nodes and spleen were collected and cleared from fatty tissue under the 
dissecting microscope. Bone marrow cells were obtained by flushing tibias with PBS.  
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Prior to antibody staining, red blood cell lysis was performed twice for blood samples 
and once for spleen and bone marrow samples by mixing the samples with 5ml 0.8% 
NH4Cl for 5 minutes on ice. 5ml PBS were added and the white blood cell population 
was separated by centrifugation. Lymph samples were washed once with 2ml PBS 
and centrifuged. Cells from lymph nodes were obtained by gently pushing lymph 
nodes through a cell strainer (40µm, Thermo Fisher Scientific, Waltham, USA) and 
washing them with 5ml PBS. 
For surface staining of leukocyte markers or chemokine receptors, except CCR7, 
each sample was resuspended in 100µl PBS containing an antibody cocktail and 
incubated at 4°C for 30 minutes. For CCR7 staining, samples were initially 
resuspended in 100µl PBS supplemented with 2µl CD16 and CD32 antibodies and 
incubated at 4°C for 15 minutes to block unspecific Fc-receptor-mediated antibody 
binding. Without washing, 1µg anti-CCR7 antibody was added and cells were 
incubated at 37°C for 30 minutes. After a washing step with PBS, a secondary 
staining round was performed as described above. Antibody clones and dilutions are 
given in Table 2.3.  
Finally, cells were washed once, resuspended in 150µl PBS and run on a flow 
cytometer (Gallios 10/3, Beckman Coulter, Brea, USA, equipped with three lasers, 
405nm, 488nm and 635nm). Data was analyzed using FlowJo (Ashland, USA).  
 
Table 2.3 Antibody clones used for flow cytometry 
Antigen Color Species Isotype Clone Company 
CD 4  APC anti-mouse Rat 
IgG2b, κ 
GK1.5 Biolegend 
CD 4 PE  anti-mouse Rat 
IgG2b, κ 
GK1.5 Biolegend 
CD 8a PerCP/Cy5.
5 
anti-mouse  Rat 
IgG2a, κ 
53-6.7 Biolegend 
CD 11b PE  anti-
mouse/human  
Rat 
IgG2a, κ 
M1/70 Biolegend 
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CD 16/32 Purified anti-mouse Rat 
IgG2a, λ 
93 Biolegend 
CD 44 APC/Cy7 anti-
mouse/human  
Rat 
IgG2b, κ 
IM7 Biolegend 
CD 
45R/B220 
PE/Cy7 anti-
mouse/human 
Rat 
IgG2a, κ 
RA3-6B2 Biolegend 
CD 62L FITC  anti-mouse Rat 
IgG2a, κ 
MEL-14 Biolegend 
CD 184 
(CXCR4) 
PE anti-mouse Rat 
IgG2b, κ 
L276F12 Biolegend 
CD 185 
(CXCR5) 
PE anti-mouse Rat 
IgG2b, κ 
L138D7 Biolegend 
CD 195 
(CCR5) 
PE anti-mouse Armenian 
Hamster 
IgG 
HM-CCR5 Biolegend 
CD 197 
(CCR7) 
PE anti-mouse Rat 
IgG2a, κ 
4B12 Biolegend 
 
2.8 T cell isolation 
 
CD4 T-cells were purified for qPCR or adoptive transfer experiments from lymph 
nodes of WT mice, CD4cre x Bmal1flox/flox, CD4cre x S1P1flox/+ or littermate 
control mice using the EasySep Mouse CD4 T-cell enrichment kit (StemCell 
Technologies), in accordance with the manufacturer’s instructions. Purity of isolated 
cells was confirmed via flow cytometry and was generally above 96 %.  
 
2.9 Quantitative RT-PCR 
 
RNA extraction from lymph nodes or isolated CD4 T-cells was performed using the 
RNeasy plus mini kit (Qiagen, Hilden, Germany), in accordance with the 
manufacturer’s instructions. To determine RNA concentration and quantity after 
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extraction, RNA samples were analyzed using a NanoDrop 2000 (Thermo Fisher 
Scientific, Waltham, USA) and stored at -80°C.  
100-200 ng RNA was used for reverse transcription into cDNA, using the High 
Capacity cDNA Reverse Transcription Kit (Applied Biosystems), in accordance with 
the manufacturer’s instructions, and cDNA was stored at -20°C.  
Quantitative real-time PCR was performed with SYBR GREEN on a StepOnePlus 
Real Time PCR System (Applied Biosystems). To determine the optimal primer 
concentrations and annealing temperatures, all primers were tested under different 
conditions. A primer concentration of 0.5µM was found optimal for each primer pair, 
whereas annealing temperatures differed depending on the primers. The sequences 
of oligonucleotides and annealing temperatures that were being used can be found in 
Table 2.4. All reactions were performed in duplicates or triplicates in a total reaction 
volume of 10 µl, containing 5 µl SYBR green, 1 µl primer mix, 2 µl H20 and 2 µl 
cDNA. The cycling conditions were one cycle at 95 °C (10 min) followed by 40 cycles 
of 95 °C (15 s) and 58-64 °C (1 min). Gene expression levels were normalized to the 
housekeeping gene glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and the 
CT method was used for relative quantification.  
 
Table 2.4 Quantitative RT-PCR primers 
 
Primers Sequence Annealing(°C) 
Bmal1_F 
Bmal1_R 
AGA GGT GCC ACC AAC CCA TA 
TGA GAA TTA GGT GTT TCA GTT CGT CAT 
62 
Clock_F 
Clock _R 
CAA AAT GTC ACG AGC ACT TAA TGC 
ATA TCC ACT GCT GGC CTT TGG 
62 
Per1_F 
Per1_R 
TGA GAG CAG CAA GAG TAC AAA CTC A 
CTC GCA CTC AGG AGG CTG TAG 
60 
Per2_F 
Per2_R 
GTC CAC CTC CCT GCA GAC AA 
TCA TTA GCC TTC ACC TGC TTC AC 
60 
Cry1_F 
Cry1_R 
CTC GGG TGA GGA GGT TTT CTT 
GAC TTC CTC TAC CGA GAG CTT CAA 
62 
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Rev-Erb-alpha_F 
Rev-Erb-alpha _R 
GAT AGC TCC CCT TCT TCT GCA TCA TC 
TTC CAT GGC CAC TTG TAG ACT TC 
60 
Dbp_F 
Dbp_R 
AAT GAC CTT TGA ACC TGA TCC CGC T 
GCT CCA GTA CTT CTC ATC CTT CTG T 
60 
S1pr1_F 
S1pr1_R 
CGG TGT AGA CCC AGA GTC CT 
AGC AGC AGA TGA GAA TGA AC 
64 
S1pr 2_F 
S1pr 2_R 
ATG GGC GGC TTA TAC TCA GAG 
GCG CAG CAC AAG ATG ATG AT 
60 
S1pr 3_F 
S1pr 3_R 
TTC CCG ACT GCT CTA CCA TC 
CCA ACA GGC AAT GAA CAC AC 
62 
S1pr 4_F 
S1pr 4_R 
TGC GGG TGG CTG AGA GTG 
TAG GAT CAG GGC GAA GAC C 
62 
S1pr 5_F 
S1pr 5_R 
CTT AGG ACG CCT GGA AAC C 
CCC GCA CCT GAC AGT AAA TC 
62 
Ccr7_F 
Ccr7_R 
TCA TTG CCG TGG TGG TAG TCT TCA 
ATG TTG AGC TGC TTG CTG GTT TCG 
62 
Cxcr4_F 
Cxcr4_R 
TCA GTG GCT GAC CTC CTC TT 
CTT GGC CTT TGA CTG TTG GT 
60 
Cxcr5_F 
Cxcr5_R 
AAA CGA AGC GGA AAC TAG AGC C 
GCC CAG CTT GGT CAG AAG CC 
60 
Ccl19_F 
Ccl19_R 
ATG TGA ATC ACT CTG GCC CAG GAA 
AAG CGG CTT TAT TGG AAG CTC TGC 
62 
Ccl21_F 
Ccl21_R 
ACA GCG GCC TCC AGA AGA ACA GCG G 
CGT GAA CCA CCC AGC TTG A 
 
64 
Cxcl12_F 
Cxcl12_R 
CAG AGC CAA CGT CAA GCA 
AGG TAC TCT TGG ATC CAC 
58 
Cxcl13_F 
Cxcl13_R 
CAT AGA TCG GAT TCA AGT TAC GCC 
TCT TGG TCC AGA TCA CAA CTT CA 
62 
Klf2_F 
Klf2_R 
ACC AAG AGC TCG CAC CTA AA 
GTG GCA CTG AAA GGG TCT GT 
60 
Klf4_F 
Klf4_R 
CTG AAC AGC AGG GAC TGT CA 
GTG TGG GTG GCT GTT CTT TT 
60 
Gapdh_F 
Gapdh_R 
TGT GTC CGT CGT GGA TCT GA 
CCT GCT TCA CCA CCT TCT TGA 
60 
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2.10 Immunofluorescence microscopy  
 
Inguinal lymph nodes were harvested and embedded in OCT (TissueTec), before 
being put on dry ice and stored at -80°C. Sections were obtained with a cryostat 
(Leica) at a thickness of 10 µm, which was found to be optimal.  
For CCL21 staining, sections were left unfixed to be able to analyze the relevant 
extracellular protein levels and directly blocked with 0.1 % BSA solution at room 
temperature for 30 minutes. After blocking, the solution was carefully soaked up with 
facial tissues and sections were stained with 2000 µl staining solution, consisting of 
1000µl 0.1% BSA, 960µl PBS, 20µl anti-PECAM-1-APC antibody, 20µl anti-Lyve-1-
FITC antibody and 20µl biotinylated anti-CCL21 antibody at 4°C. After 24 hours, 
sections were washed with PBS and stained with 2000µl PBS containing 1:300 
Streptavidin Cy3 at room temperature for 2 hours. After washing with PBS for 2 times 
sections were imaged on an Axio Examiner.D1 microscope equipped with 405, 488, 
563 and 655 nm LED light sources (Zeiss).  
For all other antibody stainings (Table 2.5), sections were fixed with ice-cold 
methanol for 10 minutes and washed with PBS. Afterwards, sections were 
permeabilized at room temperature for 30 minutes with 3800 µl PBS containing 0.5 % 
Triton and 20 % NGS and incubated at 4°C overnight with staining solution. After 
washing with PBS for 2 times sections were imaged on an Axio Examiner.D1 
microscope (Zeiss).  
 
Table 2.5 Antibodies used for immunofluorescence microscopy 
Antigen Color Species Isotype Clone Company 
CD31 
(PECAM) 
Alexa 
Fluor® 647 
anti-mouse Rat IgG2a, κ MEC13.3 Biolegend 
CD106 
(VCAM) 
PE anti-mouse Rat IgG2a, κ 
429 
(MVCAM.
A) 
Biolegend 
CD54 
(ICAM) 
Cy3 anti-mouse Rat IgG2b, κ 
YN1/1.7.
4 
Biolegend 
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PNAd PE 
anti-
mouse/human 
Rat IGM, κ MECA-79 Biolegend 
Lyve-1 Biotin anti-mouse IgG1 ALY7 eBioscience 
Streptavidin 
Alexa 
Fluor® 488 
   Biolegend 
Streptavidin Cy3    Biolegend 
CCL21 Biotin anti-mouse Goat IgG  R&D 
 
 
2.11 Quantitative imaging analysis 
 
Measurement of expression levels of chemokines or adhesion molecules on high 
endothelial venules was performed using the mask analysis tool provided within the 
Zeiss software as shown below. In the first step, a contour (yellow line) was drawn 
around HEVs to determine the area for mask analysis. Within this mask, PECAM-1 
positive areas were determined based on their expression level (blue areas) (Figure 
2.3). 
 
 
Figure 2.3 Surface expression measurements on lymph node sections 
Representative image of a lymph node section stained for PECAM-1 (violet) and CCL21 
(red) (A) A mask (yellow line) is drawn to determine the area for the mask analysis tool (B) 
PECAM-1 high endothelial cell areas (blue area) were determined for further analysis. Scale 
bar: 100µm 
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Within these PECAM-1 high areas, determining endothelial cells, expression levels of 
CCL21 and other adhesion molecules were calculated (Figure 2.4).  
To minimize non-specific signals, PECAM-1 high areas smaller than 10 µm2 were 
excluded from analysis. The mean fluorescence intensity was calculated as a 
function of area and intensity and subtracted from isotype controls.  
 
 
Figure 2.4 MFI data points from software analysis 
PECAM-1 high areas are assigned to ID numbers (column A) and their respective size in 
µm2 (column B). The corresponding MFIs of e.g. PECAM-1 and CCL21 are represented in 
column C (PECAM-1) and column D (CCL21).  
 
For investigations of CCL21 gradients, a 10 µm thick and 100 µm long line was 
drawn starting from HEV borders and pointing towards the T cell area (Figure 2.5). 
An artificial HEV border was determined using a threshold level for PECAM-1 MFI 
above 1500. The MFI of CCL21 was calculated as a relative decrease starting from 
that border in 0.85 µm steps.  
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Figure 2.5 CCL21 gradient measurement 
Representative image of a lymph node section stained for PECAM-1 (violet), Lyve-1 (green) 
and CCL21 (red). A 10 µm thick line was manually drawn to measure the MFI of CCL21 
over a distance of 100 µm, starting from a HEV (yellow line). Scale Bar: 50µm 
  
 
2.12 Mass spectrometry 
 
To determine levels of S1P in lymph and blood plasma, lymph and blood were 
collected as described above and centrifuged down at 2800rpm for 10 minutes. For 
each sample, 40µl lymph supernatant and 60µl blood plasma were stored at -80°C. 
After collection of all time points, samples were transferred to Dr. Olaf Uhl (Dr. von 
Hauner Children’s Hospital, University of Munich Medical Center), who analyzed S1P 
levels using mass spectrometry on a 1200 SL HPLC system (Agilent) coupled to a 
4000QTRAP tandem mass spectrometer (AB Sciex).  
Proteins of 20 µL sample matrix were precipitated by adding 200 µL methanol 
including D-erythro-sphingosine-1-phosphate C17 base (860641P, Avanti Polar 
Lipids) as internal standard. After centrifugation, the supernatant was used for the 
analysis of S1P by liquid chromatography mass spectrometry (LC-MS/MS) analyses 
with a 1200 SL HPLC system (Agilent) coupled to a 4000QTRAP tandem mass 
spectrometer (AB Sciex). Separation was achieved with a Zorbax SB-C18, particle 
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size 3.5 μm, 150 mm × 2.1 mm HPLC column (Agilent) and water with 0.1% formic 
acid as mobile phase A and methanol/ isopropanol (1:1) with 0.1% formic acid as 
mobile phase B. A gradient elution was used for optimal separation from 60% B to 
80% B within 7 minutes. After column cleaning at 100% B for 1 minute, the gradient 
was equilibrated for 2.5 min at 60% B before the next injection. The LC-MS/MS 
system operated in positive electrospray ionization with electron voltage of 5500V at 
400 °C. Auxiliary gas was set to 50 psi and 60 psi was used for nebulizer gas. 
Curtain gas was set to 30 psi and collision gas was set to 8 psi. Mass transitions and 
individual energies (declustering potential, collision energy, collision cell exit 
potential) were optimized by direct infusion and set as follows: m/z 380.2►264.2 (66, 
23, 18) and 380.2►82.1 (66, 49, 6) for S1P and 366.2►250.2 (61, 23, 18) and 
366.2►82.0 (61, 45, 6) for internal standard. Mass transitions were detected in 
multiple reaction monitoring mode with a dwell time of 100 ms. Quantification was 
achieved by standard calibrating curves prepared from D-erythro-sphingosine-1-
phosphate C18:1 base (860492P, Avanti Polar Lipids) at different concentration 
points in the range from 0.005 to 0.5 µmol/L (Druzd et al. 2017).  
 
2.13 Statistical analyses 
 
Data was analyzed and plotted using Prism 6 (GraphPad). For comparison of two 
experimental groups, paired and unpaired student’s t-test were performed. For 
comparisons between three or more experimental groups, either a one way analysis 
of variance (ANOVA) followed by Tukey’s comparison or a two-way ANOVA analysis 
followed by Bonferroni’s post hoc test were used. Clara I love you more than anything      
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3.1  Leukocyte numbers in lymph nodes oscillate in a 
time-of-day-dependent fashion 
 
3.1.1 Steady-state oscillations in skin draining and mesenteric 
lymph nodes 
 
To assess whether lymph node cellularity oscillated over the course of a day, our 
initial experiment was to investigate lymph node cellularity in the physiologically 
occurring, rhythmic 12h light:12h dark environment. Every 4 hours, left and right 
inguinal lymph nodes were harvested, and pushed through a cell strainer. Afterwards, 
the samples were counted and leukocyte subsets were analyzed via flow cytometry. 
Surprisingly, strong oscillations could be observed in total leukocyte numbers, as well 
as in the major leukocyte subsets, peaking at ZT13 and exhibiting a trough at ZT1 
(Figure 3.1). 
 
 
Figure 3.1 Oscillations in total cell counts and leukocyte subsets in inguinal lymph 
nodes 
(A) Lymph nodes were harvested at different time-points during the day and cellular counts 
were obtained; n=6-19 mice, one way ANOVA (B) Leukocyte subsets in inguinal lymph 
nodes over 24 hours; n=4-15 mice, one way ANOVA; counts are plotted per single lymph 
node; ZT: Zeitgeber time. ***p<0.001.  
 
 
Next, other skin draining lymph nodes (including axial and superficial cervical) and 
mesenteric lymph nodes were harvested, counted and analyzed for the distribution of 
leukocyte subsets (Figure 3.2). Similar oscillations could be observed for peripheral 
A B 
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and mesenteric lymph nodes as for inguinal lymph nodes, with leukocyte counts 
peaking around dark onset between ZT9 and ZT13 and troughing at ZT1, the onset 
of light. 
 
 
 
 
Figure 3.2 Cellular oscillations and leukocyte subsets of different peripheral 
lymph nodes  
Cell counts in (A) axillary, (B) superficial cervical and (C) mesenteric lymph nodes with 
their respective counts of leukocyte subsets, counts are plotted per single lymph node; 
n=3-12 mice, one-way ANOVA. *p<0.05, **p<0.01, ***p<0.01.  
 
 
A 
B 
C 
  Results 
- 52 - 
 
3.1.2 Lymph node oscillations persist under altered light 
regimes 
 
To investigate whether oscillations in cell counts are entrainable by environmental 
lighting conditions, mice were kept in different light regimes. Animals that were kept 
under normal 12h light:12h dark conditions (LD), were either put in constant darkness 
(DD) or exposed to a reversed light regime (DL) (Figure 3.3). In both cases (DD, and 
DL), rhythmic cell counts were sustained, indicating that they can be entrained by a 
Zeitgeber (in this case light) and that they are still observed in the absence of such a 
Zeitgeber. Both observations substantiated the bona fide circadian nature of the 
rhythm.  
 
 
Figure 3.3 Rhythms in cell counts are sustained under different light regimes 
Lymph node oscillations under dark-dark (DD), dark-light (DL) and light-dark (LD) 
conditions, normalized to peak times; CT: circadian time, i.e. time in the absence of a 
Zeitgeber, in constant darkness; n=3-15, one-way ANOVA. *p<0.05, **p<0.01. 
 
 
3.1.3 Dynamic egress and homing of cells into lymph nodes 
 
The major contributors to lymph node counts are the homing of cells into the lymph 
node via HEVs and the egress of cells out of the lymph node into efferent lymphatic 
vessels. Therefore, both processes were blocked to determine the contribution of 
homing versus egress to the observed oscillations in lymph node cell counts.  
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For this purpose, homing was blocked with anti-αL and anti-α4 antibodies, as 
described previously (Lo et al. 2005), and cell counts were measured 6 hours, 12 
hours and 24 hours post block. To block egress, FTY720 was administered and cell 
counts were measured in the same fashion as for the homing block experiments. As 
expected, blocking homing reduced cell counts, while blocking egress increased cell 
counts. Importantly, however, in both cases, oscillations in lymph node cell counts 
were abolished (Figure 3.4).  
 
 
Figure 3.4 Homing and Egress block ablate oscillations in LN counts 
Lymph node counts after homing (left panel, red line) or egress block (left panel, grey line) 
and the corresponding leukocyte subsets (middle: homing block, right: egress block); n=3-5 
mice, one-way ANOVA with Tukey’s multiple comparison test.  *p<0.05. 
 
A third process, which might affect lymph node cellularity is intranodal proliferation. 
For this purpose, proliferation was investigated by harvesting lymph nodes at two 
different time points, ZT5 and ZT13, and staining lymph node sections for Ki67. Ki67 
is a nuclear protein, which is expressed in all phases of the cell cycle (G1, S, G2 and 
mitosis), except the resting phase, thus being an ideal marker for proliferation. As 
expected from the blocking experiments, the amount of proliferation as assessed by 
Ki67+ cells per lymph node was low. In addition, no effect of time-of-day was 
observed (Figure 3.5). Thus, proliferation at steady state within lymph nodes is low 
and does not account for the strong differences seen in overall cellularity across the 
day. 
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Figure 3.5 Steady-state proliferation within lymph nodes does not occur rhythmically 
(A) Sections of lymph nodes harvested at ZT5 and ZT13 and stained for Ki67, Lyve-1 
(marker for lymphatic endothelium) and PECAM-1 (HEVs), inset: isotype stained control. 
Scale bars: 200 µm. (B) Percentage of Ki67+ cells per lymph node, n=4-5 mice; unpaired 
student’s t-test. 
 
 
 
3.2 Homing of cells into lymph nodes is under circadian 
control 
 
Homing of cells into lymph nodes via HEVs is dependent on various signals, 
including leukocyte dependent and endothelium-derived factors. Hence, the goal was 
to determine whether any of these factors was under circadian control and might 
contribute to the observed oscillations in lymph node counts. 
 
A 
B 
  Results 
- 55 - 
 
3.2.1 Homing of cells into lymph nodes is time-of-day 
dependent 
 
At first, we used adoptive transfer techniques to determine whether homing of cells 
into lymph nodes is dependent on the time of the day. We injected a mixture of 
splenocytes and lymphocytes (80:20 ratio) that were labeled with CFSE into recipient 
mice at different time points of the day and measured the amount of homed cells 2 
hours afterwards via flow cytometry (Figure 3.6). Strong differences could be 
observed in the overall number of homed cells, as well as in the different leukocyte 
subsets, suggesting that leukocyte homing is under circadian control. 
 
 
Figure 3.6 Lymph node homing is time-of-day dependent 
Amount of CFSE+ in lymph nodes after 2 hours of homing at different time points of the day. 
For each time point, a specific ratio of splenocytes and lymphocytes was used (80:20); n=3-
5, one-way ANOVA. ***p<0.001. 
 
3.2.2 Rhythmic leukocyte homing is regulated by leukocyte- and 
endothelium-derived factors 
 
The next aim was to determine the factors that contribute to time-of-day dependent 
differences in homing of cells to lymph nodes. To decipher the role of leukocyte 
versus microenvironment-derived factors, we used adoptive transfer techniques. In 
detail, we adoptively transferred cells harvested at ZT5 and ZT13 into recipient mice 
at either ZT5 or ZT13. By labeling donor cells with two different dyes, we were able to 
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see in the same mice the effect of changing leukocyte-intrinsic factors, whereas the 
usage of different recipient mice gave us a change in the microenvironment setup. 
Indeed, we saw differences in all four groups, covering all major leukocyte subsets 
(Figure 3.7).  
 
 
Figure 3.7 Leukocyte and endothelium-derived factors contribute to rhythmic LN 
homing 
ZT5 and ZT13 harvested leukocytes were stained with the fluorescent dyes CFSE or 
CMTPX and adoptively transferred into ZT5 or ZT13 recipient mice. 2 hours after homing, 
the amount of homed (CFSE+/CMTPX+) cells was determined using flow cytometry. n=6-16 
mice, one-way ANOVA with Tukey’s multiple comparisons test. *p<0.05, **p<0.01, 
***p<0.001. 
 
 
As expected from the results shown in Figure 3.6, ZT5 cell transfer into ZT5 donors 
showed the lowest homing capacity, while ZT13 cells into Z13 mice exhibited the 
highest amount of homed cells. Interestingly, intermediate levels of homing were 
observed for the ZT5 into ZT13 and ZT13 into ZT5 chimeric time points, suggesting 
contributing roles of both the microenvironment and the leukocyte in the rhythmic 
homing process.  
Leukocytes express various chemokine receptors and adhesion molecules that take 
part actively in the leukocyte adhesion cascade. Therefore we aimed to investigate at 
different Zeitgeber times the expression of chemokine receptors and adhesion 
molecules on circulating cells in blood (Figure 3.8). In general, surface expression 
levels of pro-migratory factors did not oscillate strongly, although a trend was 
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observed for CCR7 expression levels. One reason for this observation might be that 
cells, which express a higher density of homing molecules towards the beginning of 
the active phase, have already homed to lymph nodes. Therefore, analysis of blood 
leukocyte subsets at this time point may not reveal the actual oscillations in homing 
molecules. 
 
 
Figure 3.8 Integrin, selectin and chemokine receptor expression levels in blood 
Mean fluorescence intensity (MFI) levels of adhesion molecules (A) and chemokine 
receptors (B) on the surface of leukocytes; n=3-6 mice, one-way ANOVA 
 
 
Therefore, lymph nodes were harvested at different time points and stained for the 
same molecules as in Figure 3.8. Interestingly, the surface expression levels of 
CCR7 oscillated in a rhythmic fashion on all lymphocyte subsets in lymph nodes, 
whereas the expression levels of CXCR5, CXCR4, CD62L and CD11a showed either 
no oscillations or not for all lymphocyte subsets (Figure 3.9). 
 
A 
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Figure 3.9 Integrin, selectin and chemokine receptor expression levels in lymph nodes 
Lymph nodes were harvested and analyzed via flow cytometry for surface expression levels 
of adhesion molecules (A) and chemokine receptors (B) on lymphocyte subsets; n=3-5, one-
way ANOVA. *p<0.05, **p<0.01. 
 
 
As described above, time-of-day dependent differences in homing were due to 
contributions of both leukocyte and endothelium-derived signals. To investigate 
possible oscillations in factors regulating the microenvironment within lymph nodes, 
lymph nodes were harvested and cut in 10 µm sections.  
By the use of immunofluorescence markers, the MFI of adhesion molecules within 
HEVs was determined. Rhythmic oscillations could be observed for ICAM-1, VCAM-1 
and Lyve-1, whereas the surface expression levels of PECAM-1 and PNAd remained 
stable (Figure 3.10).  
 
A 
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CCL21 is one of the most prominent chemokines regulating homing of cells into 
lymph nodes (Ansel et al. 2000; Lipp et al. 2016). Thus, both surface expression 
levels of CCL21 on HEVs and mRNA levels of whole lymph nodes were determined. 
Interestingly, oscillations could be observed for both determinants (Figure 3.11). 
As leukocytes are gradient sensitive to the expression of CCL21, the gradient of the 
chemokine was analyzed within a distance of 100 µm starting from the border of 
HEVs. Indeed, also the gradient was significantly different over the course of a day 
(Figure 3.11). Towards the beginning of the active phase, CCL21 expression levels 
remained for a longer distance high compared to CCL21 levels during the resting 
phase. This phenomenon might lead to an additional boost for a more pronounced 
homing of cells towards the beginning of the active phase. 
 
 
Figure 3.10 Expression levels of adhesion molecules on HEVs 
MFI of different adhesion molecules within PECAM high areas (=HEVs) during 24 hours 
under constant darkness conditions; n=3-18 mice, one-way ANOVA.*p<0.05, ***p<0.001. 
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3.2.3 Rhythmic homing is dependent on circadian CCR7 
expression 
 
To investigate the role of rhythmic CCR7 expression in the described differences in 
homing potential, two approaches were taken, one by pharmacologically blocking 
chemokine receptor signaling and the other one by using genetically modified mice, 
which specifically lack CCR7 expression.  
In order to downmodulate chemokine receptor signaling, lymphocytes were pulse-
loaded for 10 min with pertussis toxin (PTX) prior to performing adoptive transfer 
experiments. This results in the ablation of G-protein coupled chemokine receptor 
function due to ADP-ribosylation of the Gαi-subunit, such as CCR7 (Lo et al. 2005). 
Leukocytes from two different Zeitgeber times were pre-treated with PTX and co-
injected with PBS-treated cells. No differences were seen in the homing capacity of 
PTX-transferred cells – in contrast to PBS-treated cells (Figure 3.12). This data 
strengthens the fact that rhythmic expression/engagement of chemokine receptors is 
responsible for rhythmic homing.  
 
 
 
Figure 3.11 CCL21 expression levels oscillate within HEVs and lymph nodes 
(A) Q-PCR analysis of CCL21 expression in lymph nodes over 24 hours; n=3-5 mice, one-
way ANOVA (B) Surface expression levels of CCL21 on HEVs and their relative decrease 
100 µm aside of the HEV border; n=3-18 mice, one-way ANOVA. *p<0.05. 
A B 
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Figure 3.12 Rhythmic homing is blocked upon short PTX pre-treatment 
Amount of homed cells in lymph nodes for donor cells harvested at ZT5 or ZT13. After 
labeling with fluorescent dyes, cells were either incubated with PBS or PTX for 10 minutes 
and injected into recipient mice; n=5 mice, unpaired student’s t-test. *p<0.05, **p<0.01, 
***p<0.001.  
 
A further way to determine the role of CCR7 is by investigating Ccr7-deficient mice, 
which were generously provided by Prof. Dr. Reinhold Förster (MH Hannover). Total 
lymph node counts of these mice were analyzed for two Zeitgeber times, ZT1 and 
ZT9. In contrast to WT mice, neither total cell counts nor any leukocyte subset 
oscillated, while cell counts were overall diminished as expected (Förster et al. 1999). 
When rhythmic lymph node homing was performed in the same fashion as described 
above, adoptively transferred cells harvested from Ccr7 KO mice and injected into 
WT recipients failed to show differences between the two Zeitgeber times (Figure 
3.13). 
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Figure 3.13 Lymph node cellularity and homing of Ccr7 KO mice 
(A) Inguinal lymph nodes of Ccr7-/- mice were harvested at different Zeitgeber times, 
counted and analyzed via flow cytometry. (B) Ccr7-/- cells from different Zeitgeber times 
were labeled with CFSE and CMTPX and injected into WT recipient mice. After 2 hours of 
homing, the amount of homed cells was analyzed via flow cytometry. n=4-6 mice, unpaired 
student’s t-test 
 
Together, these data show that time-of-day dependent differences in the homing 
capacity of leukocytes into the lymph node are dependent on rhythmic expression 
levels of CCR7. 
 
 
3.3 Role of clock genes in leukocyte trafficking 
 
3.3.1 Clock genes oscillate in lymph nodes  
 
To address whether circadian clock genes oscillate in lymph nodes, inguinal lymph 
nodes were harvested and clock gene expression profiles were determined for the 
most prominent clock genes (Figure 3.14). All investigated genes in the molecular 
clock machinery oscillated significantly over 24 hours. 
 
B 
  Results 
- 63 - 
 
 
Figure 3.14 Expression profiles of clock genes in lymph nodes 
Q-PCR analysis of circadian clock genes in inguinal lymph nodes over 24 hours; n=3-5 mice, 
one-way ANOVA. *p<0.05, **p<0.01. 
 
 
3.3.2 Phenotype of T- and B-cell specific Bmal1 knock-out mice 
 
As described in the introduction, BMAL1 is a crucial protein for the molecular clock 
machinery. Furthermore, it is the only single gene whose knock-out results in 
complete loss of rhythmicity (Bunger et al. 2000). As our aim was to determine the 
role of BMAL1 in T-cell trafficking, Bmal1flox/floxx CD4cre mice, which lack Bmal1 
expression in CD4 and CD8 T-cells were generated in our lab. Lymph nodes were 
harvested under steady-state conditions at four different time-points and leukocyte 
counts were obtained (Figure 3.15).  
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Figure 3.15 Leukocyte counts in T-cell specific Bmal1 knock-out mice 
Inguinal lymph nodes of Bmal1flox/floxx CD4cre mice were harvested and analyzed for 
leukocyte subsets; n=3-9 mice, one-way and two-way ANOVA. *p<0.05, ***p<0.001. 
 
Interestingly, leukocyte counts and the oscillation pattern were altered in inguinal 
lymph nodes, whereas spleen, thymus and bone marrow counts remained similar to 
control littermates (data not shown).  
The same experiments were performed in Bmal1flox/floxxCD19cre mice, which lack 
Bmal1 expression in B-cells to exclusively determine the role of BMAL1 in B-cell 
trafficking (Figure 3.16). 
 
 
Figure 3.16 Leukocyte counts in B-cell specific Bmal1 knock-out mice 
Inguinal lymph node counts of Bmal1flox/floxx CD19cre mice were harvested and analyzed for 
leukocyte subsets; n=4-5 mice, unpaired student’s t-test. *p<0.05, ***p<0.001. 
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Similar to leukocyte counts in Bmal1flox/floxx CD4cre mice, cellularity in lymph nodes 
changed the strongest and the oscillation pattern was abandoned, whereas cellularity 
in other organs was unaffected (data not shown).  
In a next step, donor leukocytes from Bmal1 T-cell specific knock-out mice were 
harvested and injected into WT recipient mice to determine whether these donor cells 
exhibited an impaired rhythmic homing capacity. Indeed, leukocytes lacking Bmal1 
failed to showed rhythmic differences in homing into lymph nodes compared to 
control cells (Figure 3.17). This suggested that a defect in Bmal1 gene expression 
altered the expression profile of homing molecules such as CCR7.  
 
 
Figure 3.17 Lymph node homing of leukocytes harvested from control and T-cell-
specific Bmal1 knock-out mice 
Lymph node homing of leukocytes harvested at different Zeitgeber times from control or 
Bmal1 T cell specific knock-out mice into WT hosts. n=10-34 mice, one-way ANOVA with 
Tukey’s multiple comparison test. *p<0.05 **p<0.01. 
 
 
To verify this hypothesis, mRNA levels of Ccr7 were investigated in isolated CD4 T-
cells from control littermates and Bmal1flox/floxxCd4cre mice. Indeed, Ccr7 levels did 
oscillate in WT mice, whereas oscillations were significantly diminished in T-cells, 
which lacked Bmal1 (Figure 3.18).  
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Figure 3.18 CCR7 surface expression and mRNA levels of control and T-cell-specific 
Bmal1 KO mice 
(A) CCR7 surface expression levels were analyzed via flow cytometry in control littermates 
and T-cell-specific Bmal1 KO mice (B) Q-PCR analysis of Ccr7 levels in isolated CD4 T-
cells of control littermates and Bmal1 deficient cells over 24 hours; n=3-5 mice, one-way and 
two-way ANOVA. *p<0.05. 
. 
 
Taken together, these data demonstrate that Bmal1 plays a critical role in maintaining 
the rhythmic homing potential observed for leukocytes. If Bmal1 gene expression is 
abolished, leukocyte fail to home into lymph nodes in a time-of-day dependent way. 
 
 
3.4  Leukocyte egress into efferent lymphatic is under 
circadian control 
 
3.4.1 Circadian oscillations in leukocyte numbers in lymph fluid 
 
To determine whether leukocyte numbers in efferent lymph show rhythmic 
oscillations, a novel technique was established in order to cannulate lymphatic 
vessels. The advantage of this mesenteric lymph vessel cannulation is the tight 
control of the time scale of cannulation and the exclusion of contamination with 
blood, compared to other techniques that puncture the thoracic duct followed by 
peritoneal lavage (Matloubian et al. 2004). Of importance, there are no differences in 
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the amount of leukocytes harvested, when comparing our method to the previously 
described technique (data not shown). 
As our previous data suggested, we also observed striking differences in the cellular 
counts within lymph fluid, where lymphocyte numbers peaked at ZT9 and exhibited a 
trough at ZT21 (Figure 3.19). 
 
 
Figure 3.19 Leukocyte and lymphocyte numbers oscillate in lymph fluid 
(A) Cell counts in efferent lymph fluid after 1 hour cannulation of a mesenteric efferent lymph 
vessel; n=6-33, one-way ANOVA (B) Lymphocyte subset numbers in efferent lymph over 24 
hours; n=6-33, one-way ANOVA. *p<0.05, ***p<0.001. 
 
As described for lymph node cellularity before, an important criterion for a circadian 
rhythm is its ability to persist at constant conditions, such as constant darkness. 
We therefore transferred mice kept under normal light:dark conditions (LD) into 
constant darkness (DD) and measured lymph counts. Indeed, also under DD 
conditions lymphocyte counts remained oscillatory in efferent lymph (Figure 3.20). 
This demonstrated their bona fide endogenous circadian nature. 
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Figure 3.20 Lymph cell counts under constant darkness 
Leukocyte numbers in efferent lymph under LD and DD conditions; n=3-37, one-way 
ANOVA. *p<0.05. 
 
 
To exclude the possibility, that the observed oscillations in leukocyte counts were not 
due to potential time-of-day dependent differences in lymph flow, lymph was 
cannulated over one hour and lymphatic flow rate was quantified. Indeed, lymph flow 
was constant over the collected time points in anesthetized mice, demonstrating that 
oscillating numbers were caused by egress-mediated effects (Figure 3.21). 
 
 
Figure 3.21 Lymph flow is constant at different Zeitgeber times 
Lymph volume and flow rate over different time points quantified over one hour of 
cannulation in anesthetized mice; n=7-22 
 
 
 
3.4.2 Leukocyte half-life in LNs is time-of-day dependent 
 
As time-of-day had a major influence on the LN homing and egress capacity of 
leukocytes, we investigated the possibility that leukocyte half-life, i.e. the time that a 
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leukocyte spends in the LN, is also dependent on the Zeitgeber time. Therefore, we 
carried out adoptive transfer experiments at ZT5 and ZT13 and - after two hours of 
homing - blocked any subsequent entering of lymphocytes into LN by administration 
of anti-integrin antibodies. Over the next 24 hours, lymph nodes and lymph was 
harvested at different times and the presence of both endogenous and adoptively 
transferred leukocyte subsets in LN and lymph were analyzed. Interestingly, at ZT13, 
endogenous cells remained significantly longer in the lymph node than at ZT5 (Figure 
3.22). A similar, albeit weaker, effect was observed for transferred cells (Figure 3.23). 
This indicates that lymphocyte egress from lymph nodes into efferent lymphatic 
vessels is highly rhythmic. 
 
 
Figure 3.22 Analysis of remaining endogenous lymphocytes in lymph nodes and 
lymph after homing block 
(A) Remaining percentage of lymphocyte subsets in lymph nodes over 24 hours after homing 
block at ZT5 and ZT13; n=3-10 mice, unpaired student’s t-test (B) Remaining percentage of 
lymphocyte subsets in lymph over 24 hours after homing block at ZT5 and ZT13; n=3-6 mice, 
unpaired student’s t-test. *p<0.05, **p<0.01. 
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Figure 3.23 Half-life analysis of adoptively transferred cells in lymph nodes and lymph 
(A) Remaining percentage of adoptively transferred leukocytes at ZT5 and ZT13 recipients 
after homing block; n=3-10 mice (B) Total leukocyte and lymphocyte numbers in lymph after 
homing block was performed at ZT5 and ZT13; n=3-6 mice 
 
 
3.4.3 Leukocyte egress and half-life is non-rhythmic in CD4 T 
lymphocytes lacking Bmal1  
 
To investigate, whether the core clock protein BMAL1 regulates lymphocyte egress, 
lymph was drawn from Bmalflox/floxxCD4cre mice over different Zeitgeber times, 
counted and analyzed for leukocyte subsets via flow cytometry. Both for CD4 and 
CD8 T-cells, rhythmic oscillations in lymph counts were abolished (Figure 3.24).  
This suggests that Bmal1 is able to regulate the egress of cells from the lymph node 
into efferent lymphatic vessels.  
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Figure 3.24 Leukocyte counts in lymph of T-cell-specific Bmal1 KO mice 
CD4 and CD8 T-cell counts in lymph drawn at different Zeitgeber times from 
Bmal1flox/floxxCD4cre mice. n=3-8 mice, one-way ANOVA. 
 
To determine, whether half-life of leukocytes in lymph nodes is under control of 
Bmal1, CD4 T-cells from Bmal1flox/floxxCD4cre mice were isolated at two different 
Zeitgeber times and co-injected together with littermate controls into wild-type mice. 
Two and twelve hours after adoptive transfer, inguinal lymph nodes of recipient mice 
were harvested and analyzed for the amount of remaining cells (Figure 3.25). As 
expected, control ZT13 donor CD4 T-cells remained significantly longer in lymph 
nodes than ZT5 donor CD4 T-cells. In contrast, however, ZT5 and ZT13 CD4 T-cells 
lacking BMAL1 protein exhibited no time-of-day dependent differences.  These 
results highlight the importance of a functional T cell clock for their rhythmic 
trafficking behavior. 
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Figure 3.25 Impaired leukocyte dwell time in Bmal1-deficient CD4 T-cells 
CD4 T-cells of littermate controls and Bmal1flox/floxx CD4cre were isolated at ZT5 and ZT13 
and injected into recipient mice. Two and twelve hours after transfer, the amount of labeled 
cells remaining in LN was analyzed using flow cytometry. Data points are shown as 
remaining cellular numbers (in %) in lymph nodes harvested twelve hours after transfer 
compared to two hours after transfer; n=4-13 mice, unpaired student’s t-test. **p<0.01. 
 
 
 
 
3.5  Rhythmic leukocyte egress is dependent on 
circadian S1pr1 expression 
 
The most important molecular pathway that regulates egress of leukocytes from 
lymph nodes into efferent lymphatic vessels is mediated via the S1P-S1P1 axis. 
Initially, we analyzed mRNA levels of all five known S1P receptors and observed 
rhythmic oscillations for all five receptors (Figure 3.26). 
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Figure 3.26 Q-PCR analysis of S1P1-5 receptors 
Relative mRNA expression levels of S1P receptors harvested from inguinal lymph nodes 
over 24 hours; n=3-5 mice, one-way ANOVA. *p<0.05, ***p<0.001. 
 
 
To investigate whether time-of-day changes in S1pr1 expression levels caused the 
rhythms in lymph fluid cellularity we blocked leukocyte egress at different time-points 
of the day. This was achieved by injection of FTY720 40 minutes prior cannulation, 
an egress modulating drug that downmodulates S1P receptors (except S1P2). 
Indeed, lymph counts were differentially affected, depending on the time of day 
FTY720 was given, suggesting a time-of-day dependent sensitivity against the drug. 
This effect was also observed, when smaller doses of the drug were administered 
(Figure 3.27).  
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Figure 3.27 Time-of-day dependent sensitivity against FTY720 
(A) Leukocyte counts in lymph fluid after blockade of S1P receptors at different time points 
of the day; n=3-33, two-way ANOVA (B) Effects of FTY720 titration at two different time-
points, n=3-5 mice. ***p<0.001. 
 
This indicated an important role for S1P1 in mediating rhythmic leukocyte egress. In 
fact, S1pr1 levels do oscillate in CD4 T-cells corresponding to overall oscillations in 
lymph counts. These oscillations were abrogated in CD4 T-cells, which lack Bmal1 
expression (Figure 3.28). 
 
 
Figure 3.28 Q-PCR analysis of S1pr1 levels in CD4 T-cells 
S1pr1 mRNA levels were analyzed in CD4 T-cells in control and T-cell specific Bmal1 KO 
mice. n=4-9 mice, one-way and two-way ANOVA. *p<0.05 **p<0.01. 
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To test whether also levels of S1P, the chemoattractant lipid that binds to S1P1, 
might be under circadian control, S1P levels in lymph and blood plasma were 
measured at different time-points of the day (Figure 3.29). In contrast to S1P receptor 
levels, concentration levels of S1P did not oscillate over the course of a day.  
This demonstrates that expression levels of S1P1 regulate time-of-day differences in 
leukocyte egress. 
 
 
Figure 3.29 Lymph and Plasma S1P levels over 24 hours 
Lymph and plasma samples were analyzed via mass spectrometry for levels of S1P, n=9-11 
mice 
 
 
3.5.1 Modulation of lymphocyte trafficking in S1pr1 gene-
targeted mice 
 
S1P1 is a major regulator of rhythmic leukocyte egress. It has been previously 
reported that complete knock-out of S1P1 abolishes leukocyte egress entirely 
(Matloubian et al. 2004).  
Therefore, we used heterozygous mice that lack one allele of the S1pr1 gene,  as it 
has been previously reported that S1pr1flox/+ mice display haploinsufficiency (Pham et 
al. 2008). As expected, we did observe diminished leukocyte counts in blood (not 
shown) and lymph due to an impaired ability of leukocyte to leave the lymph node. 
Importantly, we observed non-rhythmic lymph node counts, whereas only CD8 T cells 
remained to show rhythmic but altered lymph counts (Figure 3.30). 
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Figure 3.30 Leukocyte counts in T-cell-specific S1pr1 heterozygous mice 
Lymph (A) and inguinal lymph nodes (B) of S1pr1flox/+x CD4cre mice were harvested and 
analyzed for leukocyte subsets; n=3-6 mice, one-way and two-way ANOVA. *p<0.05, 
**p<0.01, ***p<0.001. 
 
 
As S1pr1flox/+x CD4cre mice have reduced S1P1 receptor levels both on CD4 T-cells 
and CD8 T-cells due to T-cells undergoing a CD4-CD8 double positive 
developmental stage in the thymus, a different approach was used to target S1P1 
function specifically in CD4 T-cells (Sharma & Zhu 2014). By breeding S1pr1flox/+x 
CD4ERT2 mice, these mice should lack partially the S1P1 receptor on CD4-T-cells 
after induction of the CRE recombinase and waiting the correct amount of time 
(Śledzińska et al. 2013). 5mg/day tamoxifen was given orally for five consecutive 
days and two weeks later, organs were harvested and analyzed for leukocyte counts 
(Figure 3.31). Instead of showing exclusively impaired CD4 T-cell numbers, CD8 T-
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cell counts were also altered. This indicated that also CD8 T-cells were affected by 
the treatment, which could be due to an improper time point selected for harvest.  
 
 
 
Figure 3.31 Leukocyte counts in S1pr1xCD4 inducible Cre mice  
Leukocyte counts of organs harvested from S1pr1 flox/+xCD4ert2 mice two weeks post 
tamoxifen treatment; n=3 mice, unpaired student’s t-test. *p<0.05, **p<0.01.  
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Circadian clocks have developed in unicellular and multicellular organisms during 
evolution to enable organisms to adapt optimally to environmental changes naturally 
occurring during the 24 hour light-dark cycle. In mammals, this evolution has led to 
the existence of the SCN, a central pacemaker which entrains pervasively expressed 
peripheral clocks in different organs and cell types. Furthermore, recent studies have 
strengthened the initial observations that integral parts of the immune system are 
under control of central or peripheral clocks, including immune responses to 
inflammatory diseases and adaptive immune responses against vaccines 
(Scheiermann et al. 2012; Long et al. 2016).  
However, little is known to which extent peripheral clocks, which are known to be 
expresses in leukocytes (Bollinger et al. 2011; Hemmers & Rudensky 2015), might 
drive the migratory behavior of leukocytes under physiological and pathophysiological 
conditions in secondary lymphoid organs. Although it has been shown that molecular 
clock proteins are expressed in lymph nodes and spleen (Keller et al. 2009), the 
exact role of these proteins in lymphoid tissues remained unclear. Furthermore, 
controversial results have been published as to whether leukocyte numbers exhibit 
diurnal variation regarding their cell numbers in lymphoid tissues (Litvinenko et al. 
2005; Fortier et al. 2011). The aim of this thesis was to investigate whether clocks in 
lymphocytes control the migratory behavior and functions of these cells and might 
thus play a role in the (patho)physiology of lymphatic organs.  
The experimental work presented here unveiled that clock proteins regulate rhythmic 
expressions of proteins, which are crucial for the homing to and egress of leukocytes 
from lymph nodes. Under steady-state conditions, this results in higher expression of 
chemokine receptors (CCR7 and CXCR5), chemokines (CCL21) and adhesion 
molecules (ICAM-1 and VCAM-1), which leads to a higher homing capacity of 
leukocytes towards the beginning of the active phase. Furthermore it could also be 
shown that the expression profile of the main egress molecule S1P1 is also under 
circadian control and exhibits an inverted oscillation compared to the homing and 
retention factors. These opposite oscillation patterns determine the time-scale for a 
lymphocyte to enter, survey and finally leave lymph nodes. 
Taken together, peripheral clocks modulate homing, dwell time and egress of 
leukocytes and thus actively shape rhythmic cellularity of lymph nodes. These 
rhythms were abolished by genetic disruption of T and B cell clocks. Moreover, these 
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rhythmic cellular oscillations contribute to understanding previously described 
circadian oscillations in the strength of adaptive immune responses.    
 
4.1 Cellular oscillations of leukocyte numbers in lymph 
nodes 
 
We initially determined cell counts of inguinal lymph nodes over multiple time points 
of the day, due to conflicting results in the literature. In accordance with data 
published by Litvinenko and colleagues, we detected a time-of-day dependent 
difference in the total cell counts of inguinal lymph nodes (Litvinenko et al. 2005). 
Furthermore, these oscillations in cell numbers were also detected in other skin 
draining and mesenteric lymph nodes, suggesting these oscillations to reflect a broad 
systemic phenomenon, which appears not to be restricted to the specific location of 
the lymphoid organ. To confer that these oscillations are bona fide circadian, i.e. 
persist under a changed light regime, mice were challenged either with a reversed 
dark/light cycle or kept in constant darkness. In both cases, oscillations in cell 
numbers of inguinal lymph nodes persisted, indicating their true circadian nature.  
In a next step, the detailed cell composition of lymph nodes was determined. Due to 
the work of Fortier et al, it has been assumed, that lymphocyte subsets do not vary 
over the day in murine lymph nodes (Fortier et al. 2011). Recently, this assumption 
has been revoked by a study showing clear oscillations for major leukocyte subsets 
in lymph nodes (Suzuki et al. 2016). In accordance with the latter data, we also could 
determine significant differences in the cell numbers of CD4 T-cells, CD8 T- cells, B-
cells and dendritic cells in all investigated lymph nodes. In general, leukocyte 
numbers increased towards the beginning of the active phase in these tissues, 
exhibiting a peak between ZT9 and ZT13, and decreasing towards the beginning of 
the resting phase, showing a through at ZT1. Depending on the leukocyte subset, the 
time-of-day is therefore responsible for a 2-3 fold difference in total cell numbers. 
Interestingly, the peak of lymph node oscillations occurs 4-8 hours later to previously 
described oscillations in blood leukocyte counts (Scheiermann et al. 2013; Arjona et 
al. 2012; Curtis et al. 2014). It is remarkable, that other hematopoietic organs such as 
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the thymus and the spleen do not display perceptible oscillations in absolute 
numbers (data not shown).  
Furthermore, it is well known, that overall numbers in bone marrow do not oscillate 
over 24 hours. Interestingly however, hematopoietic stem and progenitor cells 
(HSPCs) exhibit circadian differences in the mobilization into blood and the 
recruitment back into the bone marrow. Thereby, the release of HSCs from the bone-
marrow into blood peaks 5 hours after the onset of light, similar to total leukocyte 
counts in blood (Méndez-Ferrer et al. 2008). In contrast, the recruitment of HSPCs to 
the bone marrow peaked one hour after the onset of darkness (Scheiermann et al. 
2012), similar to the here observed peak in total leukocyte counts in lymph node. 
Mechanistically, both processes are mediated by a tissue specific circadian 
regulation of chemokine and endothelial cell adhesion molecules, as well as a 
circadian regulation of the adrenergic tone.  
Therefore it appears that both homing of cells into the lymph node and egress from 
the lymph node might contribute to the observed oscillations in absolute cell counts. 
Indeed, both homing block (via HEVs) with anti-integrin antibodies and lymphocyte 
egress (via efferent lymphatic vessels) block with FTY720 ablated rhythmicity 
completely over 24 hours.  
As the amount of intranodal proliferation did not change over the day, both homing 
and egress appear to be the main contributors to the observed oscillations in lymph 
node cellularity.  
 
4.2  Control of lymph node cellularity by the circadian 
clock 
 
4.2.1 Homing of cells into lymph nodes is under circadian 
control 
 
To determine whether homing of leukocytes into lymph nodes is dependent on the 
time of the day, homing experiments were performed at different zeitgeber times. 
Indeed, up to 4 fold differences in the amount of homed cells were observed, where 
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leukocytes entered lymph nodes most prominently at the onset of the night phase 
(ZT13). 
In order to enter lymph nodes, leukocytes undergo complex interactions with HEVs. 
This process is mediated by leukocyte-expressed factors, e.g. selectins (CD62L), 
integrins (CD11a) and chemokine receptors (CCR7, CXCR4, CXCR5), and 
endothelium-derived factors, e.g. adhesion molecules (ICAM-1, ICAM-2, VCAM-1) 
and chemokines (CCL21, CCL19, CXCL12, CXCL13) (Miyasaka & Tanaka 2004). 
To decipher whether leukocyte-intrinsic or endothelium-derived signals contribute to 
the observed differences in homing potential, leukocytes were harvested from ZT5 or 
ZT13 donor mice and adoptively transferred at either ZT5 or ZT13 recipient mice. As 
expected, ZT5 cells into ZT5 mice exhibited the lowest homing capacity, whereas 
ZT13 cells into ZT13 mice showed the highest amount of homed cells. Interestingly, 
intermediate levels of homing capacity were observed both for ZT5 cells into ZT13 
mice and ZT13 cells into ZT5 mice. A screen for promigratory factors on leukocytes 
revealed that exclusively the chemokine receptors CCR7 (for T and B cells) and 
CXCR5 (for B cells) exhibit rhythmic surface expression profiles, whereas other 
adhesion molecules (CXCR4, CD11a, CD62L) did not oscillate.  
Several experiments performed within this thesis underscore the fact that CCR7 is a 
crucial determinant for rhythmic leukocyte homing.  
First, rhythmic homing was blocked upon treatment of leukocytes with PTX, a 
chemical reagent, which abolishes Gαi protein-coupled receptor signalling. Second, 
Ccr7-/- mice neither exhibited any oscillations in absolute cell counts nor in leukocyte 
subsets in lymph nodes. Third, CCR7 KO cells failed to show differences in the 
homing capacity between ZT5 and ZT13, in contrast to WT cells. Fourth, both CCR7 
surface expression levels and mRNA levels do oscillate in leukocytes, peaking 
towards the beginning of the active phase when leukocyte homing is the highest. 
As the function of CCR7 is dependent on chemokine ligands, CCL19 and CCL21 
expression levels have been analyzed to test the hypothesis that the receptor as well 
as the ligand mediates rhythmic homing. Expression analyses of lymph nodes 
revealed that both mRNA levels and protein levels on HEVs of CCL21 oscillated over 
24 hours, but not CCL19 (not shown).   
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As described before, BMAL1 is a crucial protein for the molecular clock machinery. 
Furthermore, it is the only single gene whose knock-out results in complete loss of 
rhythmicity (Bunger et al. 2000). However, few studies have focused on cell-type 
specific deletion of Bmal1 to decipher its role in leukocyte trafficking. Nguyen and 
colleagues used mice which lack Bmal1 in the myeloid lineage and showed that 
Bmal1 controls trafficking of Ly6Chi inflammatory monocytes by indirectly repressing 
the expression of CCL2, a chemokine which is expressed under inflammatory 
conditions (Druzd & Scheiermann 2013; Nguyen et al. 2013). 
It was tempting to speculate, that Bmal1 might regulate in a similar fashion the 
expression profiles of CCR7 or CCL21. To test this hypothesis we generated T and B 
cell specific knockout mice to elucidate the role of Bmal1 on the regulation of 
leukocyte-derived molecules, which are involved in homing to lymph nodes. 
Interestingly, both Bmal1flox/floxx CD4cre mice and Bmal1flox/floxx CD19cre mice do not 
exhibit rhythmic leukocyte counts in lymph nodes anymore, although blood leukocyte 
counts remain oscillatory. This suggests, that Bmal1 plays indeed a crucial role in 
regulating lymph node cellularity. To determine, whether leukocytes, which lack 
Bmal1 are less capable of homing into lymph nodes, adoptive transfer experiments 
were performed with leukocytes harvested from control and T-cell-specific Bmal1 
knock-out mice at different Zeitgeber times. In fact, leukocytes, which lack Bmal1 fail 
to show time-of-day dependent differences in their homing potential. Mechanistically, 
leukocytes which lack Bmal1 do not display rhythmic CCR7 surface expression levels 
on leukocytes, nor rhythmic mRNA levels. 
As mentioned before, it might be possible that besides CCR7, the expression of the 
chemokine CCL21 is under rhythmic control, similar to the expression of CCL2 by 
Bmal1 (Druzd & Scheiermann 2013; Nguyen et al. 2013). As CCL21 is produced by 
FRCs and endothelial cells in lymph nodes, the generation of Bmalflox/floxx Lyve-1 
mice would be necessary to address this question. As both surface expression levels 
and mRNA levels of CCL21 in whole lymph nodes oscillated over the course of the 
day, a potential direct circadian regulation is feasible. Whether the adrenal axis 
governs this rhythmic expression, as has been shown for CXCL5 expression within 
the lung (Gibbs et al. 2014), or the sympathetic nervous system, as has been shown 
for both bone marrow and skeletal muscle (Méndez-Ferrer et al. 2008; Scheiermann 
et al. 2012), needs to be investigated in future experiments.  
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Taken together, the work presented in this thesis indicates that the expression profile 
of crucial molecules involved in leukocyte homing are regulated by the circadian 
clock and that thus the homing of cells into lymph nodes is time-of-day dependent.  
 
4.2.2 Leukocyte egress into efferent lymphatic vessels is under 
circadian control 
 
The egress of leukocytes from lymph nodes via efferent lymphatic vessels is, besides 
homing of cells into the organ, a further process that regulates lymph node cellularity.  
Therefore, we investigated the possibility that lymphatic egress from lymph nodes is 
under circadian control by cannulating efferent lymphatic vessels. This hypothesis is 
supported by recent data from Suzuki et al., reporting that lymphocyte populations in 
lymph oscillate over 24 hours (Suzuki et al. 2016). 
In fact, our data also show rhythms both for absolute leukocyte counts and for CD4 
T-cells, CD8 T-cells and B-cells, peaking during the resting phase (ZT9) and 
exhibiting a trough at the end of the active phase (ZT21). Importantly, these rhythms 
were independent of lymph flow and, similar to lymph node counts, were bona fide 
circadian in nature as they persisted in constant darkness.  
To examine, whether oscillations in lymph counts were truly attributable to rhythmic 
efflux of cells from lymph nodes and not due to rhythmic influx of cells into lymph 
nodes, we used an approach that has been previously described to determine 
leukocyte dwell time in lymph nodes (Mandl et al. 2012). In detail, we adoptively 
transferred leukocytes at different time points of the day, blocked lymph node homing 
2 hours later via injection of blocking antibodies and harvested every 6 hours for 24 
hours lymph nodes to quantify the amount of injected and endogenous leukocytes 
still present. Furthermore, lymph was drawn and analysed in the same manner.  
Our data reveal that leukocytes injected at ZT13 remain significantly longer in lymph 
nodes and show a less rapid accumulation in lymph, compared to cells entering 
lymph nodes at ZT5. This results in longer lymph node half-lives of leukocytes 
injected at ZT13 (CD4: 12h, CD8: 12h, B cells: 16h) compared to ZT5 (CD4: 9h, 
CD8: 9h, B cells: 13.5h). Our observed transit rates for endogenous CD4 T- cells at 
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ZT13 match nicely previously described transit times, whereas we observed 6 hour 
shorter transit times for endogenous CD8 T cells (Mandl et al. 2012).  
However, Mandl and colleagues use an exponential decay model to estimate transit 
times, i.e. a model in which T cells leave with a constant probability per unit time. Our 
data indicate though a time-dependent egress of leukocytes. Consequently, their 
mathematical model approach might lead to altered transit times as it is indeed the 
case. This hypothesis is strengthened by the fact that mice, which lack Bmal1 in T- 
and B-cells do not exhibit any oscillations in lymph counts, confirming the importance 
of circadian clock proteins for lymphocyte egress. Furthermore, adoptively transferred 
CD4 T-cells, which lack Bmal1 fail to show time-of-day differences in their lymph 
node transit time, highlighting the relevance of Bmal1 in leukocyte trafficking. 
 
In summary, our data demonstrate that egress of leukocytes from lymph nodes is 
highly rhythmic. Furthermore, the time-of-day entry of cells into lymph nodes 
determines their transit time, as leukocytes tend to survey the lymph node for 3 hours 
longer when entering the organ at the beginning of the active phase than entering 
during the rest phase. This observation may be due to it being more likely for an 
organism to encounter pathogens during the active phase than during the rest phase. 
Thus, leukocytes might increase their chances to encounter possible pathogens or 
antigens when they survey lymph nodes longer and at the right time.  
 
4.2.3 Rhythmic leukocyte egress is dependent on circadian 
S1pr1 expression 
 
The group of Jason Cyster discovered over the last decade, that retention and egress 
of leukocytes in the lymph node is mainly modulated by the fine-tuned counterplay 
between CCR7 and S1P1 (Pham et al. 2008). As soon as S1P1 is upregulated on a 
leukocyte, the S1P1 signal overrides CCR7, a homing but also retention factor, and 
leukocyte egress is promoted (Cyster & Schwab 2012).  
Thus, our hypothesis was that the expression of S1P1 might be also under circadian 
control and regulate leukocyte egress together with a rhythmic expression of CCR7.  
  Discussion 
- 86 - 
 
To investigate the role of S1P1, we generated T-cell specific mice which were 
heterozygous for S1PR1 in order to not abolish but only partially block leukocyte 
egress (Pham et al. 2008). These mice are known to have a gene-dosage-dependent 
cell trafficking defect due to haploinsufficiency (Matloubian et al. 2004; Lo et al. 
2005). As expected, S1pr1T-cell het mice do not display any oscillations in lymph node 
cellularity, but show altered lymph rhythmicity. A reason for still observing oscillations 
in lymph could be due to a still rhythmic expression of CCR7. As mentioned before, 
CCR7 is, also in S1pr1T-cell het mice, able to indirectly modulate S1P1 levels. Thus, 
leukocyte counts in lymph fluid still do oscillate, however, in an altered fashion.  
These data suggest, that S1P1 gene expression is indeed responsible for the 
observed oscillations in lymph counts and in regulating proper rhythmic leukocyte 
trafficking. Similar to the CCR7-CCL21 axis, S1P1 function is mediated by a 
chemoattractant lipid, S1P. It is known, that high S1P levels are able to downregulate 
S1P1 and a fine-tuned S1P gradient is crucial for leukocytes to exit lymph nodes 
(Schwab et al. 2005; Pappu et al. 2007). However, we did not detect any oscillations 
in S1P levels, neither in lymph nor in blood. Consequently, merely the receptor 
(S1P1) and not the ligand exhibits a rhythmic expression profile. This hypothesis is 
strengthened by the fact, that titrated amounts of FTY720, a drug which antagonizes 
S1P1 receptor function, demonstrate a clear time- and dose-dependent reduction of 
lymph cellularity with increased FTY720 concentrations. 
In fact, we detected strong oscillations of S1pr1 mRNA levels in isolated CD4 T-cells, 
peaking at ZT7 and coinciding with high lymph counts. Interestingly, these S1pr1 
oscillations were abolished in mice which lack the circadian core gene Bmal1 in CD4 
T-cells, indicating that Bmal1 is able to regulate S1pr1 expression. In fact, data which 
was generated in the lab of our collaborator Henrik Oster using a luciferase assay did 
show, that Bmal1 is able to regulate S1P1 expression (Druzd et al. 2017). Although 
this data set suggests a negative regulation of Bmal1, this does not necessarily have 
to be the case, as clock mRNA and protein level rhythms usually do not occur at the 
same time but are often out of phase by several hours.  
Chawla and colleagues describe that the cytokine genes Ccl2 and S100a8 are 
negatively regulated by BMAL1/CLOCK and these also exhibit only a slightly shifted 
profile to Bmal1 - similar to S1pr1 – peaking around ZT4 (Nguyen et al. 2013). The 
silencing of these cytokines occurs through the recruitment of a repressor complex to 
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the genes. The S1pr1 gene exhibits several non-canonical E-boxes indicating a 
possibility that BMAL1/CLOCK heterodimers might also repress expression of S1pr1 
in this manner. 
 
Taken together, our data demonstrate that a crucial gene, which regulates leukocyte 
egress is under circadian control. Interestingly, the S1pr1 expression profile (high 
during the rest phase, low during active phase) is inverse to CCR7 oscillations (low 
during rest phase, high during active phase). These opposite rhythms make sense, 
as CCR7 can antagonize S1P1 function due to its role as a retention factor for 
leukocytes (Pham et al. 2008). Furthermore, the expression of CD69, a negative 
regulator of S1P1 (Shiow et al. 2006), is also inverse to the S1pr1 expression profile. 
Although we did not investigate whether CD69 is also regulated by circadian genes, 
previously published studies suggest this mode of action. Specifically, the circadian 
gene Per1 might be responsible for the upregulation of CD69 towards the beginning 
of the rest phase, as it downregulates the transcription factor Sox6, which itself is a 
negative regulator of CD69 (Le et al. 2013; Miyamoto et al. 2016). Altogether, a fine-
tuned circadian machinery is responsible for the timing of leukocyte egress. 
 
4.3  Outlook 
 
Numerous studies have unravelled that integral parts of the innate immune system 
are under circadian control (Keller et al. 2009; Scheiermann et al. 2012; Nguyen et al. 
2013; Gibbs et al. 2014). Although it has been recently shown that differentiation of 
leukocytes and critical factors of adaptive immunity are regulated by the circadian 
clock (Yu et al. 2013; Silver et al. 2012), little is known to what extent the circadian 
system orchestrates leukocyte trafficking. 
The results of the work presented in this thesis expand our understanding of the 
mechanisms, which underlie leukocyte trafficking under steady-state and 
inflammatory conditions. Having established that the circadian clock in leukocytes 
drives rhythmic gene expression of pro-migratory molecules and together with 
rhythmic expression of endothelium-derived factors thus contributes to rhythmic 
leukocyte trafficking in lymph nodes, it would be beneficial to investigate the 
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contribution of other inputs to leukocyte trafficking. In fact, it has been recently 
reported that neural input to β2-adrenergic receptors expressed on leukocytes 
regulates leukocyte egress from lymph nodes (Suzuki et al. 2016). It might be thus 
possible, that parts of the leukocyte adhesion cascade might be under control of 
different peripheral clocks, regulated by glucocorticoids or the sympathetic and 
parasympathetic nervous system as it has been shown for bone marrow and skeletal 
muscle (Scheiermann et al. 2012). 
The work contained in this thesis has already been published within a larger project, 
investigating in addition to the molecular mechanism, which govern rhythmic 
leukocyte trafficking, the relevance of oscillatory lymph node counts for adaptive 
immune response and vaccination timing (Druzd et al. 2017). Within this paper, our 
data indicate that also the adaptive immune response to bacterial and viral infections 
is rhythmic. Furthermore, in a model of experimental autoimmune encephalomyelitis 
(EAE), immunization at the beginning of the active phase led to a higher immune 
response compared to immunization during the rest phase. Transferring this 
knowledge to humans, early morning hours should produce higher antibody titres. 
Indeed, preliminary studies could show that morning vaccination is associated with 
enhanced antibody responses (Phillips et al. 2008; Long et al. 2016).  
In recent years, the term of chronopharmacology has become a new determinant in 
the treatment of diseases. In this context, research has provided evidence that the 
circadian system most prominently influences the activity of enzymes which are 
responsible for the metabolization of drugs, such as CYP P450 (Druzd et al. 2014). 
However, little is known to which extent diurnal differences in the expression profile of 
target molecules influence a drug’s toxicity and efficacy. Our data indicate a time-of-
day dependent sensitivity of Fingolimod, a drug, which has been used in the clinic 
since 2010 to treat multiple sclerosis. Due to the rhythmic expression profile of the 
drugs target, S1P1, treatment with 10% of the normal dose lead to a similar effect in 
leukopenia in our hands. Taking this knowledge into the daily clinical treatment 
routine could result in both lowering side-effects for the patient and lowering costs in 
healthcare. Hence, future research in the field of chronopharmacology will lead to 
improved therapeutic practises and the development of better drug strategies.               
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